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The aim of this study is to develop highly enantioselective allylic addition 
reactions catalyzed by chiral bicyclic guanidines. 
A chiral bicyclic guanidine was found to catalyze a direct asymmetric 
allylic addition reaction to imines. This reaction provides enantio-enriched 
maleimides and succinimides that can be used to prepare aza-heterocycles with 
multiple chiral centers. NMR studies and deuterium-exchange experiments 
were used to study the intermediates in the reaction 
We have also found that the chiral bicyclic guanidine was also efficient to 
catalyze enantiodivergent -selective allylic amination of β,γ-unsaturated 
carbonyl compounds.  Both enantiomers with high enantioselectivity and 
yield were achieved.  The computational studied revealed the possible 
originality of the inversed enantioselectivity and diastereoselectivity.  The 
methodology was elegantly utilized in the synthesis of biologically and 
pharmaceutically important g-Aminobutyric acid derivatives and 
(+)-Zwittermicin A core structure.    
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Introduction to the Enantioselective Allylic Addition 
 and Substitution Reactions 
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1.1 Overview of Enantioselective Allylic Addition and Substitution 
Reactions. 
    The fast development of enantioselective transformation methodologies enables 
efficient synthesis of optically pure compounds, which can be utilized in synthesis 
of pharmaceutical intermediates or natural products.  Among these transformations, 
asymmetric allylic substitutions or additions are significant because it is applicable 
to a wide range of bond formations, chirality induction methodologies, and 
synthesis of natural products which otherwise hard to achieve.   
    Up to now, several general methods to functionalize the allylic position have 
been reported: (a) stoichiometric amount of chiral auxiliary promoted asymmetric 
addition to carbonyl compounds; (b) the catalytic enantioselective addition of 
allylic organometallic reagents to carbonyl compounds; (C) the transition metal 
catalyzed enantioselective allylic substitution reaction; (d) the organocatalyst 
promoted enantioselective allyic addition reaction.  Significant attentions have 
been paid on the first three methodologies over decades.  However, the obvious 
advantages of the fourth strategy inspire the chemists to put great efforts on it.  
Herein, this chapter gives an overview on all the methodologies.  Chiral auxiliaries, 
derived from natural chiral pool, were employed in asymmetric allylic reactions 
almost at the same time as in other enantioselective reactions.  Both high 
enantioselectivity and diastereoselectivity can be achieved by carefully tuning the 
reaction parameters.  Nevertheless, these chiral modifiers may expensive and not 
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readily available, which obstructs the usefulness of this methodology.  Allylic 
organometallic reagents were enantioselectively added to the carbonyl compounds 
with Lewis acid, base or transition metal as the chiral promoter, which enable the 
asymmetric additions with wide substrate scope.  Again, both high 
enantioselectivity and diastereoselectivity can be obtained.  However, the 
generation of stoichiometric amount of waste deteriorates the significance of the 
methodology.  Transition metal catalyzed enantioselective allylic addition and 
substitution reactions are the most widely studied asymmetric allylic reactions and 
many reviews and books were published on this topic.  These transition metal 
catalyzed enantioselective allylic addition and substitution reactions, in particular 
the asymmetric allylic alkylations, were employed in the asymmetric natural 
product synthesis.  The usage of toxic transition metals and generation of 
stoichiometric amount of waste are drawbacks of the methodology.  Last but not 
the least, the organic catalyst promoted asymmetric allylic substitutions is an 
emerging area for this important transformation and is still at the data collection 
stage.  This thesis is based on such background and wish to develop a highly 
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1.2 Stoichiometric Asymmetric Allylic Addition to Carbonyl 
Compounds. 
    Before catalytic asymmetric allylic substitution and addition reactions were 
developed, chiral auxiliaries were utilized in enantioselective allylmetal reagents 
addition reactions to carbonyl compounds.  In general, the chiral auxiliaries can 
either attached to the allymetal reagents, the carbonyl compounds or both.
1
  Syn 
and anti type products can be achieved using γ-substituted allylmetal reagents, and 
the alkene group can be further functionalized to provide carbonyl compounds 
(Scheme 1.1).  
 
Scheme 1.1 Allylic addition of allylmetal reagents to aldehydes. 
    The configurational stability of a γ-substituted allylmetal compound is 
important if the (E)- or (Z)- isomer is to be utilized for a stereoselective addition 
reaction.
2
  Therefore, for the stereoselective formation of C-C bonds only 
allylmetal compounds in which E/Z isomerisation is suppressed are useful.  The 
most commonly used allylmetal compounds of the third-group elements are those 
of boron.  The tendency of allyl boron compounds to undergo metallotropic 
rearrangement can be controlled by proper choice of substituent on the boron atom.  
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The placement of π-donor atoms, such as oxygen or nitrogen, on boron raise the 
energy of the vacant boron p-orbital that the trihapto-structure does not readily 
form and thus rearrangement is often entirely suppressed.  (E)- and (Z)- allylboron 
derivatives with two oxygen atoms on boron (i.e. boronate esters) are sufficiently 





 and titanium compounds
6
 are also stable and useful in 
stereoselective addition to aldehydes. 
 
Scheme 1.2 Diastereoselective addition of crotylboronates to aldehydes. 
    Of the large number of allylmetal compounds available, boronic acid esters are 
amongst the most useful for enantioselective allylic additions.  Stereochemically 
defined (E)- and (Z)-crotylboronates are readily available and configurationally 
stable at or slightly above room temperature.  Some early studies on additions of 
allyl and crotylboronates to chiral aldehydes were conducted independently by the 
groups of Hoffmann and Roush.
7
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Scheme 1.3 Diastereoselective addition of allylic boronates to α-chiral aldehydes. 
    A number of additions of allylboronate 5 to chiral aldehydes have been reported 
by Hoffmann and the majority proceeds preferentially by the Felkin-Anh mode of 
attack (Scheme 1.3).   Roush examined the addition of boronate 5 to α-oxygenated 
chiral aldehydes 3 and 4 and found that the reactions again proceeded under 
Felkin-Anh control; however, in these cases the α-oxygen is the large group in the 
transition state. 7     
 
Scheme 1.4 Diastereoselective addition of allylchromium to chiral aldehydes. 
    The addition of crotylchromium compounds to aldehydes gives the anti isomer 
as the major product regardless of their configuration.  Allylchromium reagents are 
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generated in situ from the corresponding allylic halides and CrCl2 or CrCl3/LiAlH4 
in THF (Scheme 1.4).
8
   
The Lewis acid promoted reactions of allylsilanes and stannanes also proceed 
with good stereocontrol.  Heathcock et al. investigated the reaction of allylsilanes 
with simple chiral aldehydes in the presence of Lewis acids and found that 
additions to α- and β-alkoxy aldehydes show exceptional diastereofacial 
preference.
9
  The SnCl4-mediated addition of allyltrimethylsilane to aldehyde 7 
gives the alcohol 8 in high de. (Scheme 1.5).   
 
Scheme 1.5 Lewis acid mediated addition of allyltrimethylsilane to aldehyde. 
The addition of allyl and crotylstannanes to chiral aldehydes can often give 
higher selectivities than those observed for silanes.  Keck and Boden reported that 
the addition of allyl tributylstannane to aldehyde catalyzed by MgBr2 proceeded 





Scheme 1.6 Stereocontrolled additions of allyltri-n-butylstannane to α-
hydroxyaldehyde derivatives.  
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 Brown and co-workers achieved highly optically pure homoallylic alcohols by 
attaching optically active organic groups to boron as chiral auxiliary.  The most 
common chiral dialkylboranes are those derived from the chiral terpene α-pinene 
which is readily available in both the (+)-form and the (-)-form.  
 
Scheme 1.7 Enantioselective addition of diisopinocampheylboranes to aldehyde. 
The so-called diisopinocampheylboranes react readily with a range of aldehydes 
at -78 °C to provide the corresponding condensation products in high ee.
11-15
  The 
simple R,R-tartrate-modified boronate esters described by Roush’s group are 
alternatives to the alkylborane reagents.
16,17
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Scheme 1.8 Asymmetric allylation of aldehydes with allyltrichlorosilane. 
The allylation of carbonyl compounds with allylsilanes under Lewis acidic 
conditions has been extensively studied.  The allyltrichlorosilane modified by a 
chiral diol via a chiral pentacoordinate silicate was reported addition to aldehydes 
gave optically active alcohols with up to 71% ee (scheme 1.8).
18,19
  By replacing 





Scheme 1.9 Asymmetric allylation of aldehydes with allysilane.  
    Mukaiyama et al. reported  asymmetric allylation of aromatic aldehydes using 
chiral allylic tin reagents, generated from 2λ2-1,3,2-benzodioxastannole, allyl 
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halides, chiral tartrates and organic base, in the presence of catalytic amount of 
copper salts to afford the corresponding homoallylic alcohols in high yields and 




Scheme 1.10 Asymmetric allylation of aromatic aldehydes using chiral tin 
reagents. 
 
1.3 Catalytic Enantioselective Addition of Allylic Organometallic 
Reagents to Carbonyl Compound. 
    The common strategy of modifying allylic organometallic reagents with chiral 
ligands for stereoselective allylation is well studied for allylic boranes, allylic 
boronates, allylic silanes and allylic stannanes.  However, stoichiometric amount 
of chiral modifiers, most of which are expensive and not readily available, is 
required.  Thus, it is not practical for large scale reactions.  Catalytic 
enantioselective methods which aims to solve the problem emerged and can be 
extended to three categories by overarching rubric of reaction types and group 
reagents.
22
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Scheme 1.11 Three types of allylic addition of organometallic reagents to 
aldehydes.  
 
    Type I reactions: chiral Lewis bases catalyzed addition of allylic trichlorosilanes; 
type II reactions: Lewis acids catalyzed addition of allylic organometallic reagents 
(Si, Sn, B), predominantly syn diastereoselectivity observed; type III reactions: in 
situ generated allylic organometallic reagents (Cr, Zn, In) from allylic halides 
addition catalyzed by chelating ligands, predominantly anti-selective independent 
of starting allylic geometry. 
 
Scheme 1.12 Addition of allylsilanes catalyzed by CAB. 
    The first example of type II reactions catalyzed by chiral Lewis acid were 
reported by Yamamoto in 1991 using chiral acyloxy borane (CAB) (Scheme 
1.12).
23
  The catalyst is effective for the addition of substituted allylic silanes to 
aromatic aldehydes.  Up to 98/2 er and 97/3 syn/anti selectivities of the 
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homoallylic alcohols were observed regardless of the geometry of the starting 
silane.  
 
Scheme 1.13 Addition of allylic organometallic reagents to aldehydes catalyzed 
by BINOL/Ti(IV) Complexes. 
 
    Titanium complexes of the readily available 1,1’-binaphthalene-2,2’-diol 
(BINOL) with Ti (IV) Lewis acids as catalysts were most extensively studied in 
these type II allylation reactions.  Mikami prepared the catalyst in situ by mixing 
TiCl2(O-i-Pr)2 and (S)-BINOL in the presence of 4 Å molecular sieves and provide 
the addition of allylsilane and allylstannane to methyl glyoxylate with syn adduct 







 further extended the study to aliphatic and 
aromatic aldehydes respectively.  Both afforded the homoallylic alcohols in high 
yields and enantioselectivities.  It is proposed that a BINOL/Ti(IV)-allyl complex 
activates the aldehyde toward nucleophilic attack.  The opposite enantioselectivity 
was observed by replacing the (S)-BINOL with its enantiomer (R)-BINOL.  
Attempts to use allylic stannane reagents prepared in situ from Sn(II) and allylic 
bromide complexes in the allylation reaction has been reported, however, with 
much lower er compared to the direct usage of allyl tin reagents.
27
 
The success of the BINOL/Ti(IV) catalyst systems inspired a significant effort 
to improve the reactivity limitations and extension of the reaction scope.  In this 
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 and Silicon Tetrachloride/bis-phosphoramide
35,36
 complexes were 
broadly studied.  Type III reaction is the most promising among these three 
categories because it does not require the preparation, isolation and handling of 
toxic or sensitive reagents.  The chromium-mediated addition of allylic halides, 
which was firstly reported by Hiyama
37
, to aldehydes is the most useful example 
of this type reaction.   Umani-Ronchi first achieved a catalytic, enantioselective 
version of this reaction by in situ reduction of the CrCl3 with an excess of Mn, 
followed by coordination with the salen ligand to form the chiral complex.  Up to 




Scheme 1.14 Chromium-Mediated allylation reaction. 
Other than previously described pathways, a mechanistically distinct process 
utilizing the Lewis bases to catalyze the allyation would have greater 
stereochemical control and generality over the Lewis acid catalysis system.
22
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Table 1.1 Addition of allylic trichlorosilanes to benzaldehyde promoted by (R,R)-
14. 
 
silane 14, equiv Yield, % Anti/syn er 
15 1.0 80 -- 80/20 
(E)-16 1.0 68 98/2 83/17 
(Z)-16 1.0 72 2/98 80/20 
15 0.1 40 -- 76.5/23.5 
 
    Denmark et al. reported the addition of allyltrichlorosilane 15, (E)-16, (Z)-16 to 
benzaldehyde, with a stoichiometric amount of chiral phosphoramide 14 derived 
from (R,R)-trans-1,2-cyclohexanediamine as the promoter, providing the 
homoallylic alcohol in high yield, but with modest enantioselectivity (er 80/20) 
(Table 1.1). Interestingly, anti and syn adducts were afforded by the addition of 
(E)- and (Z)-16, respectively, with high diastereoselectivities, which supports the 
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Scheme 1.15 Addition of allylic trichlorosilanes to aldehydes catalyzed by 17. 
    Further optimization of the Lewis base catalyst revealed that 5 mol% loading of 
17 was able to catalyze the addition of aromatic, heteroaromatic and unsaturated 
aldehydes in good yields and selectivities (Scheme 1.15).
40
 
Chiral N-oxides were also reported as another class of efficient catalysts for the 
addition of allylic trichlorosilanes (Scheme 1.16).
41-43
  Both high enantio-
selectivities and diastereoselectivities were obtained in the addition of (E)- and 
(Z)-2-butenylsilanes, suggesting a six-membered, chair-like transition state.  
Further development of more reactive N-oxide catalysts by Hayashi et al. led to 
higher reactivity (more than 90% yield was obtained). 
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Scheme 1.16 Addition of allyltrichlorosilane catalyzed by N-oxide. 
1.4 Metal-Catalyzed Enantioselective Allylation Reactions. 
    The transition metal-catalyzed enantioselective allylic addition and substitution, 
typically the asymmetric allylic alkylation reaction (AAA reaction), occupies a 
significant position among the asymmetric allylic functionalizations.  Quite a few 
reviews were published based on this topic.  In contrast to most metal-catalyzed 





centers.  The ability to transform achiral, prochiral or racemic 
compound to enantiopure compound under similar conditions is unique to the 
asymmetric allylic alkylation reaction.  From the mechanistic point of view, the 
general catalytic cycle of the AAA reaction offers at least five opportunities for 
enantiodiscrimination, and in some instances, more than one mechanism is 
operative when chiral elements at the electrophile and nucleophile are set in the 
same reaction.  The cycle involves olefin complexation, subsequent ionization of a 
leaving group, and then nucleophilic addition and decomplexation.  Except for the 
decomplexation of the olefin from the metal-ligand system, where the chirality has 
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Pd is the dominant transition metal for the catalytic asymmetric allylic 
substitution and addition reactions.  High diastereo- and enantioselectivities could 
be achieved when combined with appropriate ligands.
46
  Other metals which have 













.  To date, most of the successful ligands 
for the transition metal catalyzed allylic substitution reactions fall into one of the 
three categories.  One employed a secondary interaction of the nucleophile and a 
side chain of the ligand to direct the approach of the nucleophile to one of the 
allylic terminal carbon atoms.  One increased the ligand coordination angle to 
create a chiral cavity in which the allyl system is embedded.  The other one 
employed heterodonor ligands to discriminate two allylic terminal carbon atoms 
electronically.  However, recent approaches have been focusing on the 
development of novel ligands and the usage of transition metals which are not well 
developed before.   
1.4.1 Novel Ligands in Transition Metal Catalyzed Asymmetric Allylic 
Substitution and Addition Reactions. 
    In general, for the Pd catalyzed asymmetric substitution reactions, high 
enantioselectivities were observed in unhindered disubstituted linear substrates and 
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low in hindered substrates.  Thus, novel ligands which can overcome these 
limitations are required.   
Biaryl phosphate moieties have been reported to be highly advantageous in 
ligand design due to its tolerance of the substrate specificity.  This is because the 
chiral pocket created is flexible enough to enable the perfect coordination of both 
hindered and unhindered substrates.  The larger π-acceptor ability of the biaryl 
phosphate moieties increases the reaction rates as well as the regioselectivity 
toward the desired branched isomer in monosubstituted linear substrates.  On the 
synthetic point of view, biaryl diphosphite, phosphate-oxazoline, and phosphate-
phosphoroamidite ligands are easily synthesized in two steps from the 
commercially available alcohols.   
Figure 1.1 Diphosphite ligands. 
Diphosphite ligands 19-21 were reported to give high enantioselectivities in 
asymmetric Pd-catalyzed allylic substitution of monosubstituted substrates (Figure 
1.1).  The presence of bulky substituents (tBu group) at the ortho- and para- 
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position is crucial for the high enantioselectivity.  It was also found that there is a 
cooperative effect between the configuration of the biaryl moiety and the 
configuration of the ligand backbone.  The ligand 20, which combines 
glucofuranoside backbone with tetra-tert-butyl-biphenyl phosphate moieties, 
emerged as a privileged structure as it can control the size of the chiral pocket to 
achieve high versatility. 














        The combination of the oxazoline unit with a phosphane affords many 
bidendate P,N ligands which are highly effective for standard allylic substitution 
reactons.
46
  Introduction of the ferrocene unit or chiral auxially chiral ligand also 
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b
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leads to a series of highly enantioselective chiral N,P ligands, respectively.
46
  
Recently, first example of the phosphine-oxazolines in asymmetric Pd-catalyzed 
allylic substitution reactions was reported by Pfaltz and Prétôt.
54
 This system 
overcomes the problem of regioselectivity in the allylic alkylation of 
monosubstituted linear substrates.   
 
Figure 1.2 Summary of the best results in the Pd-catalyzed allylic substitution 
using phosphine-oxazolines. 
    The application of the phosphine-oxazoline ligands to the Pd-catalyzed allylic 
substitution reactions enables excellent activities (high TOF), regio- (up to 99%) 
and enantioselectivitities (ee up to >99%).
55
  The presence of a π-accepting 
flexible bulky biphenyl phosphate moiety allows the creation of a more flexible 
chiral pocket and enhances the SN 1 character of the nucleophilic attack, which 
enables the ligands with higher versatility than their analogues.  It should be noted 
that the substituents on the oxazoline is crucial for the high enantioselectivity.  For 
hindered substrates, a phenyl substituent is required; while for unhindered 
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substrates, more sterically hindered substituents (tBu and iPr) are needed.  
Opposite enantiomer can be obtained by simply changing the configuration of the 
oxazoline substituent. 
    Other than phosphate and phosphoroamidite ligands, phosphite-
phosphoroamidite ligands were successfully used in asymmetric catalysis with 
combined advantages of the two ligands.  The phosphate-phosphoroamidite 
ligands offer the opportunity of an electronic differentiation while maintaining a 




Figure 1.3 Typical phosphite-phosphoroamidite ligands. 
1.4.2 Molybdenum-Catalyzed Asymmetric Allylic Alkylations. 
    The transition metal is crucial for the regioselectivity, reactivity toward different 
nucleophiles and practical aspects including the stability and cost in the 
asymmetric allylic substitution and addition reactions.  Recently, the Pd analogous 
Mo-catalyzed reaction has been studied and developed into a powerful synthetic 
procedure that the reaction site occurs mostly on the more substituted carbon atom 
when unsymmetrical substrates are used. 
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    The vast range in oxidation states (from -4 to +6) and the flexible coordination 
number (from 4 to 8) makes Molybdenum a very versatile metal in catalysis.
58
  Its 
ability to form π-allyl complexes enables it to be used in allylic alkylation 
reaction.
59
  A number of chiral ligands have been combined with Molybdenum to 
catalyze the asymmetric allylic alkylations.  The first Mo-catalyzed asymmetric 
allylic alkylation was reported by Trost and Hachiya.
60
  The catalyst was premade 
by heating bis(pyridylamide) and Mo salt at 60 °C in tetrahydrofuran for 1 h.  The 
nucleophile, sodium dimethyl malonate, was added with the allylic substrate 27 at 
room temperature and stirred for 3 h.  Excellent regio- and enantioselectivities 
were obtained (Scheme 1.17).  
 
Scheme 1.17 Mo-catalyzed asymmetric allylic alkylation. 
Some other pyridylamides are used as ligands in the reaction of 27 with 
dimethyl malonate (Figure 1.4).  The results obtained are summarized in Table 1.3.  
Replacing picolinamide group in 28 by a nicotinamide group or a benzoylamide 
group gave higher regioselectivities.  Quinoline analogues 34 and 35, like 6-
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substituted derivatives of 28, were less efficient as ligands in the reaction.  Non-
C2-symmetric ligands 38 and 39 give region-selectivities between 8:1 and 32:1 and 
enantioselectivities between 78% and 98%, which demonstrate that C2 symmetry is 
not a requirement for highly efficient ligands. 




Ligand % yield 29:30 % ee 
31 93 46:1 99 
32 90 60:1 99 
33 35 1:1 24 
34 29 19:1 98 
35 traces   
36 95 30:1 98 
37 95 19:1 99 
38 65 8:1 92 
39 68 32:1 98 
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Figure 1.4 Different pyridyl- and quinolylamide ligands 31-39. 
    Pfaltz et al. developed another class of ligands for the Mo-catalyzed asymmetric 
allylic alkylations (Figure 1.5 40-42).  These ligands substituted the pyridine rings 
with dihydrooxazole rings, leaving the cyclohexylamide part of the 
bispryidylamide ligands unmodified.  Additional stereogenic centers in the 
heterocyclic rings affected the outcome of the reaction, especially the 
regioselectivity.  Bispyridines ligands 43-45 were also synthesized and 
complexation to Mo(CO)6 in the asymmetric reactions.
61
  However, poor 
diastereoselectivity (4:1 to 7:1) and low enantioselectivity (8% and 22% ee) were 
obtained.  The turnover numbers were low, and catalyst decomposition was 
observed. 
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Figure 1.5 Bis(dihydrooxazole) and Bispyridine ligands 40-45. 
Metal-catalyzed asymmetric allylic alkylations are very useful synthetic tools in 
construction of new C-C and C-X bond adjacent to a double bond, which can be 
further utilized via various process in a diastereoselective manner.  Palucki et al. 
reported dynamic kinetic asymmetric transformation (DYKAT) with an 
intramolecular cyclopropanation to form a new chiral 3,4-disubstituted 
cyclopentanone 46, which is a key intermediate of a new drug candidate 47 
(Scheme 1.18).  This process gave high region- and enantioselectivity (19:1 
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Scheme 1.18 Mo-catalyzed asymmetric allylic alkylation in the synthesis of drug 
intermediate. 
    Tipranavir 49, a nonpeptidic human immunodeficiency virus (HIV) protease 
inhibitor, was synthesized by combined use of Mo- and Pd-catalyzed DYKAT 
(Scheme 1.19).
63
  Pfaltz et al. reported a Mo-catalyzed DYKAT as the key step in 
the synthesis of (R)-baclofen 51 (Scheme 1.20).
64
  High region- and 
enantioselectivities were obtained by the use of ligand 28. 
Scheme 1.19 Mo-catalyzed asymmetric allylic alkylation in the synthesis of 
Tipranavir. 
 
Scheme 1.20 Mo-catalyzed asymmetric allylic alkylation in the synthesis of (R)-
baclofen. 
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1.5 Organocatalyst Catalyzed Enantioselective Allylic Addition. 
    Highly region- and enantioselective metal-catalyzed allylic addition/substitution 
reaction has been summarized as a powerful synthetic tool in the previous part of 





be synthesized through one of these methodologies.  However, drawbacks 
including waste generation, high cost (expensive metal catalyst) deteriorate 
significance of the metal catalyzed methodologies. Thus, new methodologies 
which can bring benefits like cost saving, environmental friendly is under 
developing in parallel with the improvements of metal-catalyzed methodology.  
Organocatalysis, which is complimentary to transition metals in promoting 
reaction rates and induction of asymmetric information in other enantioselective 
reactions, has introduced into the allylic addition/substitution reactions.  Both 
chiral Brønsted base, Lewis acid and nucleophilic catalysts show good selectivity 
and wide potential in certain reactions (see below).  Nevertheless, less 
organocatalyst examples were reported in the asymmetric allylic addition reactions 
compared to the transition metal catalyzed version.   
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Scheme 1.21 Mannich-Type reaction/isomerization sequence with a β,γ-
unsaturated esters or cyanides. 
    Shibasaki et al. reported a series of asymmetric addition of allyl cyanides or β, 
γ-unsaturated esters to different electrophiles using soft Lewis acid catalysts/ hard 
Brønsted bases cooperative catalysts (Scheme 1.21).
65-70
  The ternary catalytic 
system comprising a soft Lewis acid/hard Brønsted base, in which allylic cyanide 
was chemoselectively activated by Cu
+
 through a soft-soft interaction and 
deprotonated by a neighboring Brønsted base to give an α-C-Copper active 
nucleophile.  Basicity of the hard Brønsted base Li(OC6H4-p-OMe) can be further 
enhanced by phosphine oxide through a hard-hard interaction.  The resulting 
regioselectivity for either α- or γ-addition depends on the combination of 
substrates and the catalyst used.  More specifically, α-adducts was obtained with 
ketoimines as electrophiles, while γ-adducts was obtained with aldehydes or 
ketones as electrophiles.   
 
Scheme 1.22 Orgnocatalytic γ-amination of α,β-unsaturated aldehydes.    
Jørgensen et al. reports a new concept to direct functionalize α,β-unsaturated 
aldehydes by chiral amine 53, which distinguished itself from β- and α-
functionalization of α,β-unsaturated aldehydes (Scheme 1.22).71,72  The reaction is 
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general for α,β-unsaturated aldehydes with a β-monosubstituted double bond.  
Linear aliphatic chains gave moderate yield and more than 88 % ee.  Addition of 
alkylidene cyanoacetates to acrolein was reported utilizing cinchona alkaloids as 
chiral bases (Scheme 1.23).
73
  However, this work requires the activated alkenes as 
nucleophiles. 
 
Scheme 1.23 Organocatalytic allylic amination. 
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2.1 Introduction to Guanidine Catalyst. 
 
 
  The guanidinium functional group is present in many natural products, which 
often show significant biological activities.
1
 Among the well studied guanidinium 
derivatives, marine guanidine alkaloids such as crambescidins and ptilomycalin A 
(Figure 2.1, 58) have served as targets for several total syntheses due to their 
pharmacological activities such as antiviral, antifungal, and anti-HIV.
2
  The active 
sites of many enzymes contain the amino acid arginine (Figure 2.1, 59). The 
guanidinium side chain possesses a high pKa value; therefore it remains protonated 
over a wide pH range, including at physiological pH.  It is well known to interact 
with anionic groups such as phosphates, nucleotide bases, and carboxylate-
containing biomolecules through double hydrogen bonding. In the 1980s, many 





Figure 2.1 Structures of natural products 58 ptilomycalin A, crambescidines, and 
L-arginine 59. 
Considering the high pKa value of the guanidines, they are widely used as 
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strong bases in synthetic organic chemistry.
4
  Chiral guanidine derivatives function 
as asymmetric catalysts by exploiting the high basicity of the guanidine group and 
the double hydrogen bonding of the guanidinium ion.  Chiral guanidine catalysts 
are generally classified into five categories: acyclic guanidines with chiral side 
chains, mono-to-polycyclic guanidines, axial chiral guanidines, guanidinium salts, 
and bifunctional guanidine catalysts.  Among them, the bicyclic guanidines drew 
our attention and been widely applied in the asymmetric reactions.  In 1999, Corey 
and Grogan initially designed the C2-symmetric bicyclic guanidine 60 and applied 
it to catalytic asymmetric Strecker reaction (Scheme 2.1).
5
 Moderate to good ee 
values were achieved. Subsequently, Berg et al. reported that the bicyclic 
guanidine 60 was able to catalyze the transamination reaction involved in the 1,3-
proton shift of imines with modest ees.
6
  Further optimization is still required 
before applying the methodology for the natural product synthesis (Scheme 2.2).  
 
Scheme 2.1 Bicyclic guanidine 60 catalyzed enantioselective Strecker reaction. 
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Scheme 2.2 Enantioselective transamination reactions of an imine catalyzed by 
bicyclic guanidine 60. 
Our group reported the bicyclic guanidine 65 catalyzed conjugate addition of 
α-fluoro-β-ketoesters to N-alkyl maleimides, provided chiral quaternary 
fluorinated carbon products in high enantio- and diastereoselectivities (Scheme 
2.3). This method allows the convenient preparation of chiral fluorinated 
compounds. The products obtained were not only in high enantioselectivities but 




Scheme 2.3 Bicyclic guanidine 65 catalyzed enantioselective and diastereo-
selective reactions between α-fluoro-β-ketoester 66 and N-alkyl maleimides. 
 
 Subsequently, it was discovered that chiral bicyclic guanidine 65 was effective 
in catalyzing phospha-Michael reactions of nitroalkenes. Excellent 
enantioselectivities were generally obtained for various nitroalkenes with di-(1-
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naphthyl) phosphine oxide at –40 °C.8  
 
Scheme 2.4 Bicyclic guanidine 65 catalyzed phospha-Michael reaction of various 
diaryl phosphine oxides to conjugated aryl nitroalkenes. 
 
Tan’s group reported that bicyclic guanidine 65 was also efficient in catalyzing 
the tandem conjugate addition and enantioselective protonation reaction.
9
 
Optically pure analogues of cysteine and cystine could be obtained using this 
methodology.  Highly enantioselective deuteration reaction could also be achieved. 
A small but significant level of kinetic isotope effect was also observed. 
Scheme 2.5 Bicyclic guanidine 65 catalyzed enantioselective protonation 
/deuteration reactions of various 2-(substituted-phthalimido) acrylates. 
By using bicyclic guanidine 60, Tan and co-workers reported the first case of 
highly enantioselective base-catalyzed Diels-Alder reaction between anthrones and 
various dienophiles (Scheme 2.6).
10
 Both Diels-Alder and Michael adducts were 
obtained in excellent yields, high regioselectivities and high enantioselectivities.  
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Scheme 2.6 Bicyclic guanidine 60 catalyzed Diels-Alder reaction between 
substituted anthrones and maleimides. 
 
Moreover, bicyclic guanidine 65 was found to catalyze enantioselective 
Mannich reaction between α-fluoro compounds and imines for the synthesis of α-
fluorinated β-amino acid derivatives with high regioselectivities and high 
enantioselectivities.
11
 A transient enolate was obtained via retro-Claisen or 
decarboxylation followed by protonation to give enantiopure fluorinated 
compounds.  
 
Scheme 2.7 Bicyclic guanidine 65 catalyzed Mannich reaction between β-keto 
acyloxazolidinone 75 and N-Eoc imines. 
 
Considering the excellent ability of guanidine derivatives as Brønsted base in 
catalyzing the previous reported enantioselective reactions, we supposed that 
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guanidine catalyst might be able to realize high region- and enantioselectivity in 
allylic addition reactions.  This new methodology could be a potential extension of 
the organocatalysis which already emerged as alternative to metal catalysis in the 
enantioselective functionalization of allylic position.  Based on this assumption 
and the importance of development new enantioselective allylic functionalization 
methodology for synthesis of biological active molecules and to reduce/avoid 
weak points of   existing methods, extensive studies were carried out in our 
laboratory which will be reported in the following chapters. 
 
 
2.2 Bicyclic Guanidine Catalyzed Direct Allylic Addition. 
 
 
2.2.1  Deuteration Study on N-phenyl Itaconimides. 
 
 
Scheme 2.8 Bicyclic guanidine 65 catalyzed Enantioselective protonation of 
itaconimides with thiol donor. 
 
Previously, we have successfully demonstrated that N-phenyl itaconimides were 
good electrophiles in enantioselective protonation reactions (Scheme 2.8).
9, 12
 In 
the transformation, we observed that isomerisation of the alkene in N-phenyl 
itaconimides can occur and led to the thermodynamically more stable maleimide 
derivatives under basic conditions (Figure 2.1).  We hypothesized that the α-
protons of the N-phenyl itaconimides are acidic enough to be activated by an 
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organobase, which leads to formation of a α-anion of α, β, γ-unsaturated ketone.  
The following deuteration could be able to trap either α- or γ-deuterated product 
depended on whether a kinetic (α-deuteration) process or a dynamic (γ-
deuteration) process occurs.     
 
  
Figure 2.1 Deuteration reaction of 77 studied using NMR. Reaction was carried 
out using 0.02 mmol of 77 and Et3N in 2 mL CDCl3 and 1 mL D2O. A) 77 before 
deuteration; B) 6 hours; C) 24 hours; D) 48 hours; E)  one week. 
To support this hypothesis, a deuteration-isomerization experiment was 
designed. A 1:1 mixture of N-(3,5-difluorophenyl) itaconimide 77 and 
triethylamine was monitored in a solvent mixture of CDCl3/D2O (3:1) with NMR.  
To our surprise, both the α-protons and γ-protons in itaconimide 77 were 
deuterated under this basic condition. Further analysis of the isomerization process 
revealed the existence of intermediate 79. At 6 hours, the ratio between protons a, 
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b, and c was observed to be 1:0.5:1 and this provided support for this intermediate. 
As the time of isomerization increased, the equilibrium shifted towards maleimide 
and full deuteration was achieved for all the protons. 
 
2.2.2  Bicyclic Guanidine Catalyzed Direct Michael Addition to Nitrostyrenes. 
 
 
 Inspired by this observation, we envisioned a Brønsted-base catalyzed 
asymmetric allylic addition using N-phenyl Succinimides as nucleophiles. 
Nitrostyrenes were first screened as electrophiles (Scheme 2.9).  To our surprise, 
2,6-dichloro-phenyl nitrostyrene gave good enantioselectivity without the 
observation of γ-addition products.  Further optimization of the reaction condition, 
89% ee was obtained when chlorobenzene was used as solvent.  Unfortunately, 
only 82b gave the promising result and the other substrates gave moderate yield 
and ee (less than 70%).  Electrophiles other than nitrostyrenes needed to be further 
investigated.  
 
Scheme 2.9 Bicyclic guanidine catalyzed -selective direct allylic Michael 
addition of 2-methylene-N-aryl succinimide 80a with nitrostyrene 81. 
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2.2.3  Bicyclic Guanidine Catalyzed Direct Mannich Type Addition to Imines. 
 
 
Scheme 2.10 Bicyclic guanidine catalyzed -selective direct allylation reaction of 
2-methylene-N-aryl succinimide 80a with N-Eoc protected imine 83d. 
 
Table 2.1 Optimization on -selective direct allylation reaction of 2-methylene-N-
aryl succinimide 80a with N-Eoc protected imine 83d (scheme 2.9). 
 





1 Toluene 72 25 69 
2 THF 72 80 55 
3 Hexane 72 32 76 
4 Ethyl Acetate 60 55 49 
5 DCM 72 90 80 
6 CHCl3 72 90 83 
7 Chlorobenzene 48 100 76 
8 ClCH2CH2Cl 29 100 68 
a 
Conversions were determined by TLC. 
b 
Chiral HPLC analysis. 
 
N-3-Ethylpentan-3-yloxycarbonyl (Eoc) imines were previously shown by our 
group to be excellent electrophiles in bicyclic guanidine-catalyzed enantioselective 
Mannich reaction.
 11
  They were also screened in the asymmetric allylic addition 
reactions as electrophilic candidates.  Preliminary studies using succinimide 80a 
revealed that direct allylic addition to N-protected imines resulted in amine 84 as 
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the only product via α-addition followed by 1,3-proton shift (Scheme 2.10).  No 
product resulting from the γ-addition was observed. 
We utilized N-Eoc protected imine 83d to test the solvent effect on the 
enantioselective -selective direct allylation reaction (Table 2.1). Common 
solvents including toluene, THF, Et2O and DCM were tested. DCM gave the 
highest enantioselectivities with 80% ee (Table 2.1, entries 1-5).  Thus, a series of 
chlorinated solvent were subjected to test and CHCl3 offered slightly higher 
enantioselectivity compared with DCM (Table 2.1, entries 6-8). However, 
changing the temperature and concentration did not affect the ees. 
    In the presence of 10 mol% guanidine 65, N-aryl substituted succinimides 77 
and 80b-d added to N-Eoc imines with high regio- and enantioselectivities (Table 
2.2).  However, 3 equivalents of imines were required to compete with the 
background reaction, isomerization of the succinimides to maleimides.  The 
substituents on the phenyl ring affected the reaction rates as well as 
enantioselectivities (Table 2.2, entries 1-4).  Among these subsituents, 77 bearing 
3,5-difluorophenyl aryl group resulted in adducts with the highest enantiomeric 
excess.  Thus, succinimide 77 was selected to investigate the reaction with a series 
of N-Eoc imines (entries 5-10).  No γ-addition products were observed and good 
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Table 2.2. -Selective direct allylation reaction of 2-methylene-N-aryl succin-
imide 77, 80b-d with N-Eoc protected imines. 
 
 





1 80b 83a 84a 24 92 86 
2 80c 83a 84b 48 80 84 
3 80d 83a 84c 24 83 81 
4 77a 83a 84d 10 92 87 
5 77a 83b 84e 10 90 77 
6 77a 83c 84f 10 90 77 
7 77a 83d 84g 10 91 83 
8 77a 83e 84h 10 90 87 
9 77a 83f 84i 10 91 82 




determined by chiral HPLC. Absolute configurations were 
determined by X-ray structure analysis. 
Subsequently, we examined the influence of substituted double bond on the 
succinimides towards this Mannich-type allylic addition reaction.  Succinimides 
85a-c (Table 2.3) were prepared in a simple, one step and E-selective protocol.
13
 
The 1,3-proton shift after the initial addition was no longer favorable. A highly 
diastereoselective reaction was obtained with dr that is generally >98:2.   The anti-
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selective reaction provided rapid entry to amines with two contiguous chiral 
centers in high enantioselectivities.   
Table 2.3. Mannich-type allylic addition between benzylidene-N-aryl succin-
imides 85a-c and N-Eoc imines. 
  







1 85a 83a 86a 80 99:1 85 
2 85b 83a 86b 82 98:2 84 
3
c
 85c 83a 86c 83 99:1 83 
4 85a 83b 86d 84 91:9 78 
5 85a 83d 86e 90 99:1 85 
6 85a 83e 86f 80 99:1 85 
7 85a 83f 86g 83 87:13 82 
8 85a 83g 86h 81 99:1 84 
a
 Isolated yield; 
b 
determined by chiral HPLC, the relative configurations of the 
two consecutive chiral centers were determined by X-ray structure analysis. 
c
 
reaction time was 48 hours.  
 
When the phenyl group on the double bond was replaced with an ester group, 
the reaction rate was much enhanced (Table 2.4).  Reactions were completed 
within 4 hours even with a lower catalyst loading.  The ratio of N-Eoc imines was 
reduced to 1.5 equivalents without observation of the isomerized product.  The 
bulky substituent of the ester group slightly affects the enantioselectivity.  i-Propyl 
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group exhibited better enantioselectivity over the other two substituents.   
However, the overall enantioselectivities were compromised compared with other 
two series of succinimides. Only the α-addition product is observed and once again 
the 1,3-proton shift reaction was favorable in producing maleimides 88a-g.   
Table 2.4. Mannich-type allylic addition between esterlidene-N-aryl succinimides 
87a-c and N-Eoc imines.  
 





1 97a 83a 88a 92 71 
2 87b 83a 88b 90 80 
3 87c 83a 88c 92 77 
4 87b 83b 88d 84 71 
5 87b 83d 88e 88 75 
6 87b 83f 88f 83 73 
7 87b 83g 88g 86 70 
 a
 Isolated yield; 
b 
determined by chiral HPLC, absolute configurations were 
determined by X-ray structure analysis. 
 
2.2.4  Isotopic Labelling Study and the Proposal of the Mechanism. 
Isotopic labeling is widely used to study chemical reactions. In this method 
specific atoms are replaced by an isotope in a reactant molecule which then 
participates in a chemical reaction. With the development of spectroscopy, mass 
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spectroscopy or nuclear magnetic resonance spectroscopy for example, it is 
possible to identify where a particular molecular fragment in the reactant ends up 
as a particular fragment in the reaction products.  Deuterium labeling study of 
products and intermediates in catalytic reactions provides valuable information on 
the reaction pathways and the structure of the intermediates.
14
  Useful deuterations 






.  Several 
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To gain further insight into the mechanism, deuterium labelling experiments 
were carried out using a mixture of organic solvent and D2O. Succinimide 77 
yielded 80% terminal deuterated product 89 with single deuterium labelled on 
terminal methyl group (Eq. 1). This deuterium is likely resulted from a 1,3-proton 
shift and the terminal methyl is not expected to be acidic enough to undergo 
further deuteration.  Succinimide 85a provided a α-deuterium, -amine adduct (Eq. 
2).  The stabilizing effects of the phenyl substituent on the double bond, through 
conjugation, prevented the isomerisation process from occurring.  On the other 
hand, deuteration of the two γ-protons on 91 indicated that isomerisation of the 
double bond from exocyclic to endocyclic is reversible or that the -protons next 
to the ester group is sufficiently acidic to be replaced under reaction condition (Eq. 
3). 
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Scheme 2.11 Proposed reaction sequences of -selective direct allylation reaction 
of succinimide 77. 
 
Based on the previous experimental results, we hypothesized the potential 
reaction cycle (Scheme 2.11).  2-Methylene-N-phenyl Succinimide 77 was 
deprotonated by the bicyclic guanidine 65 to form the dienoate, which would 
attack the N-3-Ethylpentan-3-yloxycarbonyl (Eoc) imine 83d from either α- or γ-
position.  The addition occurred from the α-position and led to the α-adduct 
intermediate.  Under the reaction condition, abstraction of the relatively acidic α-
proton led to an isomerisation process.  The catalyst was released to complete the 
reaction cycle.  The whole reaction is a tandem Mannich-like addition followed by 
an isomerisation of the double bond from exocyclic to endocyclic.   
In summary, we successfully developed an asymmetric allylic nucleophlilic 
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addition reaction to imines. The reaction provided enantio-enriched maleimides 
and succinimides that can potentially be used to prepare succinimides with 
multiple chiral centers. NMR studies and deuterium exchange experiments were 
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3.1 Introduction to γ-Selective Allylic Addition Reactions. 
The enantioselective functionalization of α- and β-positions of carbonyl compounds 
has exhibited its value in construction of valuable chiral molecules with a stereocenter α 
or β to a carbonyl group.  Many catalytic methodologies, using either metal- or organic-
based catalyst system to activate enolate addition to electrophiles and nucleophilic 
addition to the α,β-unsaturated carbonyl compounds, have been developed.1-3 However, 
Compared to the wide approaches to functionalize the α- and β-positions of the carbonyl 
group, little reports have been focused on the enantioselective γ-functionalization 
reactions (Scheme 3.1).
4
  Trost first reported a phosphine catalyzed nucleophilic addition 
to electron-poor alkynes and allenes at the γ-position.5-7  The process was preferred if 
nucleophilic addition occurred faster than the isomerisation of electron-poor alkynes and 
allenes to 1,3-dienes.  Soon after, Fu developed an array of asymmetric nucleophilic 
addition reactions catalyzed by chiral phosphine derivatives (Eq. 1).  Jørgensen et al. 
reported a Brønsted base catalyzed direct enantioselective γ-amination, where activated 
alkylidene cyanoacetates and malonitriles were used as nucleophiles (Eq. 2).  The same 
group further extended the approach by employed proline derivatives to enantioselective 
γ-functionalization of the α,β-unsaturated aldehyde (Eq. 3).   
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Scheme 3.1 Organocatalytic asymmetric allylic addition system. 
Phosphepine 92a and its derivatives were tested as nucleophilic catalysts in the 
enantioselective γ addition of nitromethane to allenes.  Good enantio excess and yield at 
room temperature were obtained by a racemic allene with a Weinreb amide 95 (Scheme 
3.3).  Under optimized reaction condition, phosphepine 92a serves as an effective catalyst 
for the enantioselective formation of a carbon-carbon bond and a new γ stereocenter.  The 
R substituent can range in size from methyl to sterically demanding isopropyl and can 
bear a variety of functional groups.  
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Scheme 3.2 Phosphine catalysts employed in the asymmetric γ-addition. 
 
Scheme 3.3 Phosphine-catalyzed asymmetric γ-addition of nitromethane to allenamides. 
 
Recently, Fu further expanded the scope of the γ-selective carbon-carbon bond 
formation by using malonate esters as nucleophiles (Scheme 3.4).  Phonsphepine 92d, 
which was originally developed as a chiral ligand for transition metals, was combined 
with 2-Methoxyphenol to afford the highly enantioselectivity and good yield.  
Mechanistic study revealed that the resting state of the catalyst during the γ-addition 
process was phosphepine 92d itself (not the salt form).  The rate law for the reaction was 
first order in catalyst and in allene, zero order in malonate.   
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Scheme 3.4 Phosphine-catalyzed asymmetric γ-addition of malonate esters to γ-
substituted allenoates. 
 
Trost and Li reported the first asymmetric cyclization of hydroxyl-2-alkynoates catalyzed by 
the chiral spiro phosphepine 93 (Scheme 3.5).
5
  Fu et al. applied the cyclolization to a variety of 
substrates with substituents at α, β or γ position of the hydroxyl group, providing both 




Scheme 3.5 Phosphine-catalyzed enantioselective synthesis of tetrahedrofurans and 
tetrahydropyrans. 
 
Chiral sulfur-containing compounds show important application as antibiotics, ligands 
for metal-based catalysts, and chiral auxiliaries.  Fu et al. developed the phosphepine 94 
catalyzed asymmetric γ functionalization with sulphur nucleophiles to achieve highly 
enantioselective sulfur compounds (Scheme 3.6).
9
  TangPhos 94, originally designed by 
Zhang as a ligand for  Rh-catalyzed asymmetric hydrogenations of olefins
10
, together 
with a carboxylic acid additive, served as a useful catalyst system, furnishing the γ-
sulfenylated product in up to 83% yield and 92% ee.  
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Scheme 3.6 Phosphine-catalyzed asymmetric γ-addition of thiols to allenoates. 
 
α,α-Dicyanoalkenes are materials which are readily available by the condensation of 
the corresponding carbonyl compounds and malononitrile.  Those electron-deficient 
alkenes inherently behave as electrophiles.  Over the past few years, some significant 
progress has been achieved by using α,α-dicyanoalkenes as vinylogous donors in C-C 
bond formation and other functionalization reactions, especially for the construction of 
multifunctional products.
11
  Chen et al. reported the first direct asymmetric vinylogous 
Michael addition of α,α-dicyanoalkenes 102 to nitroalkenes, employing (DHQD)2PYR as 
the organocatalyst (Scheme 3.7).
12
  The vinylogous adducts 103 were generally obtained 
in high regio-, diastereo- and enantioselectivities for a range of nitroalkenes bearing aryl 
or heteroaryl groups.  Jørgensen et al. reported the same asymmetric Michael addition of 
α,α-dicyanoalkenes to nitroalkenes.13  Aryl-, heteroaryl- and alkyl-substituted 
nitroalkenes gave clean products in 82-99% yield with 53-98% ee.  
 
Scheme 3.7 Enantioselective Michael addition of ,-dicyanoalkenes to nitroalkenes. 
 
Chen et al. investigated the allylic-allylic alkylation of α,α-dicyanoalkenes with 
Morita-Baylis-Hillman (MBH) adducts by the catalysis of tertiary amines (Scheme 3.8).
14
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A broad range of α,α-dicyanoalkenes  and MBH adducts were explored under the dual 
catalysis of (DHQD)2AQN and (S)-BINOL, delivering the multifunctional compounds 
105 with excellent stereoselectivities (dr 99 : 1, up to 98% ee). 
 
Scheme 3.8 Asymmetric allylic–allylic alkylation. 
Chen et al. also developed the direct asymmetric vinylogous Mannich reaction of N-
Boc aldimines and α,α-dicyanoalkenes via the synergistic activation of a chiral 
bifunctional thiourea-tertiary amine organocatalyst 106 (Scheme 3.9).
15  
Excellent 
stereoselectivities have been achieved for a broad spectrum of substrates (99% de, 96 to 
99.5% ee).  Up to 1000 substrate/catalyst ratio could be applied without effects on the 
enantioselectivity.   
 
Scheme 3.9 Direct asymmetric vinylogous Mannich reaction catalysed by a bifunctional 
thiourea-tertiary amine. 
 
    Jøgensen et al. reported an enantioselective metal-free allylic amination of α,α-
dicyanoalkenes with di-tert-butyl azodicarboxylate.  With the modified cinchona alkaloid, 
(DHQ)2PYR, as the optimal organocatalyst, the γ-aminated products 109 were obtained 
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in up to 91% ee enantioselectivities (Scheme 3.10).
16
 In addition, the adducts 109 have 
been efficiently converted to some valuable compounds. 
 
Scheme 3.10 Brønsted base catalyzed enantioselective allylic amination. 
The challenge of the asymmetric vinylogous approach overlays on the high electron 
density at C2 position of the dienolates, which makes the addition kinetically favourable 
at the α position over the reaction at the γ position.  In the previous example, activated 





Scheme 3.11 Organocatalytic γ-amination of α,β-unsaturated aldehydes. 
To avoid the use of low pKa nucleophiles, proline derivatives were employed to the 
direct asymmetric γ-functionalization of α,β-unsaturated aldehydes by transforming an 
electron-poor alkene into an electron-rich diene (Scheme 3.11).
18
  However, moderate 
yields of the γ-aminated products were generally obtained, which might be due to the 
polymerization of the aldehyde and the product under the given reaction conditions.   
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3.2 Introduction to Enantiodivergent Asymmetric Synthesis. 
In chemical transformations, the synthesis of individual enantiomers is generally 
achieved by using chiral natural sources.  Those chiral sources such as chiral amino acids, 
amines, carboxylic acids, and carbohydrates can function as chiral catalysts or auxiliaries.  
However, sometimes enantiomers of the S- and R-forms are quite limited in the natural 
chiral pool.  For example, most amino acids have the S configuration.  In general, a well-
designed chiral catalyst or auxiliary gives one enantiomer as the major product.  It is 
difficult to produce both enantiomers of a target from the same chiral starting source.  
Only a few examples have been reported where the same reaction system offers both 




.  Therefore, efforts on 
producing both enantiomers from the same chiral source are paid attention to.  
 
Scheme 3.12 Reversal of enantioselectivity by complementary behaviour of Rh and Ir 
catalysts. 
 
Moberg et al. reported the transition metal catalyzed hydrosilylations of acetophenone, 
exchanging Rh for Ir affords the product with the opposite absolute configuration 
(Scheme 3.12).
21
  The hydroxyl group attached to PHOX ligand 112 was expected to 
interact with high valent metal ions via oxygen coordination, which led to different 
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Scheme 3.13 Antagonistic metal-directed inductions in catalytic asymmetric aziridination 
by manganese and iron tetramethylchiroporphyrins. 
 
Catalytic asymmetric aziridination of styrene by [N-(p-toluenesulfonyl)-amino]-
phenyliodinane was promoted by manganese and iron tetramethylchiro-porphyrins with 
opposite enantioselectivity (Scheme 3.13).
22
  Since the MnCl (TMCP) complex is 
structurally very similar to FeCl (TMCP), the author suggested that the electronic effects 
were responsible for the opposite enantioselectivities.  Manganese catalyst was able to 
stabilize a radical intermediate which then led to an internal rearrangement.   
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Scheme 3.14 Chiral aminoalcohol catalyzed enantioselective reduction reactions. 
 
Furthermore, few organocatalysts promoted enantiodivergent reactions have been 
reported, which were mainly utilizing L-proline and its derivatives, as well as cinchona 
alkaloids.
23-26
 A remarkable reversal of enantiofacial selectivity in the asymmetric 
reduction of ketones with borane is demonstrated when the β-amino alcohols were used 
(Scheme 3.14).
23
  The steric effect of the diphenyl group in 114b was an important factor 
leading to the formation of the S configuration, while the steric effect of the cyclohexyl 
group enforced the approach of the chiral auxiliary to the opposite face of the carbonyl 
group.  Thus, the structure of the β-amino alcohol chiral auxiliary plays an essential role 
in controlling the asymmetric reduction in carbonyl compounds, and either enantiomer of 
the secondary alcohol can be obtained by choosing the appropriate catalyst.  
It was reported that the E/Z-configuration of the enoates influences the outcome of 
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enantioselective protonation reaction through the LTC concept (Latent Trigonal Center 
concept).
27
  Alexakis et al. examined the influence of double bond geometry on the 
copper catalyzed asymmetric conjugated addition reactions.
28
  The opposite enantiomers 
were obtained (Scheme 3.15) when a phenyl group was attached to the double bond.  The 
π electron delocalization of the phenyl substituent on the copper complex forced the 
copper complex to recognize the β-carbon atom.  Therefore, modification of the double 
bond geometry changed the nucleophilic approach which occurred at the opposite face to 
give the same enantiomer.  On the contrary, by replacing a phenyl group with a butyl 
group, modification of the double-bond geometry did not influence the nucleophilic 
approach, which is interesting for discussion but out of the thesis scope.  
 




3.3 Bicyclic Guanidine Catalyzed γ-Selective Enantioselective Allylic 
Amination.  
Our previous work reported that the N-aryl succinimide derivatives can be deprotonated 
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by the bicyclic guanidine to achieve the α-alkylidene-β-hydroxy maleimide derivatives 
with good enantio- and diastereoselectivity.  But when we employed the dimethyl 
itaconate, linear analogue of the N-aryl succinimide derivatives, no reaction can be 
observed under the same reaction condition.  This work indicated that the relatively low 
pKa value of the N-aryl succinimide derivatives may rely in the five membered ring 
structure.  Thus, we wished to design a new methodology using the bicyclic guanidine as 
the Brønsted base to activate linear allylic protons without the help of any strong electron 
withdrawing groups. 
Previous study has shown that bicyclic guanidine 65, though not basic enough to 
deprotonate commercially available dialkyl malonates, was efficient to catalyze low pKa 
nucleophiles such as dithiomalonates in asymmetric Michael reactions.
29
  The dual 
electron withdrawing groups (thioesters) not only increased the acidity of the α-
hydrogens of the nucleophiles but also benefited in the orientation of the reaction 
intermediates. We hypothesized that with the help of adjacent vinyl group, the acidity of 
the α-hydrogens next to the unactivated thioester might be enhanced to facilitate the 
deprotonation under mild conditions.
30
  Thus, we synthesized substrate 118a by simple 
DCC coupling reaction of commercially available 3-Hexenoic acid and 2-Methyl-2-
propanethiol.  Though the reaction between 118a and di-tert-butyl azodicarboxylate could 
not be completed within 24 h (Table 1), we were encouraged that the α-hydrogens of the 
(E)-β,γ-Unsaturated thioesters were able to be deprotonated under certain reaction 
condition with moderate asymmetric induction (65% ee).  Further screen of different (E)-
β,γ-unsaturated thioesters were carried out, more bulky linear substrate 118b exhibited 
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almost same reactivity and selectivity (67% ee).  The aromatic (E)-β,γ-unsaturated 
thioesters reacted significantly faster with the di-tert-butyl azodicarboxylate, although 
enantioselectivity was not improved.  However, by switching the solvent to nonpolar 
solvents such as di-iso-propyl ether (Table 1, entry 8) and tert-butyl methyl ether (Table 1, 
entry 9), excellent enantioselectivities were observed.  No α-amination products were 
isolated even after elongated reaction time, which exhibited the excellent regioselectivity 
of the reaction system.  These preliminary results are in contrary with the previous 
reported guanidine catalyzed enantioselective Mannich addition reactions (see Chapter 2) 
where α-Mannich products were predominantly obtained.  One assumption here is that 
the two reaction paths leading to α-adduct and γ-adduct have different transition state 
energies.  Computational investigation is undergoing to give an explanation by 
calculating the transition state energies but no conclusive results can be obtained now. 
 
Table 3.1. γ-Selective direct allylic amination of (E)-β,γ-Unsaturated thioesters with 
dialkyl azodicarboxylates. 
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1 118a 119c 120a 24 DCM 40 65 
2 118b 119c 120b 24 DCM 30 67 
3 118c 119c 120c 4 DCM 80 53 
4 118d 119c 120d 4 DCM 85 69 
5 118e 119a 120e 4 DCM 83 50 
6 118e 119b 120f 4 DCM 84 58 
7 118e 119c 120g 4 DCM 85 73 
8 118e 119c 120g 4 (iPr)2O 90 90 
9 118e 119c 120g 4 TBME 89 92 
a
 isolated yield; 
b
 determined by chiral HPLC.  Absolute Configuration was determined 
by X-ray structure analysis of 120 derivative. 
    Based on the promising results, the scope of the (E)-β,γ-unsaturated thioesters was 
evaluated for the bicyclic guanidine catalyzed allylic γ-amination reactions.  With 10 mol% 
catalyst loading, single γ addition products were achieved.  Long chain (entry 5, Table 2), 
branched (entry 4, Table 2), and functionalized (entry 7, Table 2) subsitutents in the 
allylic position consistently gave good yields and excellent enantioselectivities. 
Table 3.2. γ-Selective direct allylic amination of (E)-β,γ-unsaturated 1-naphthyl thioesters 
with di-tert-butyl azodicarboxylate. 
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118e [R = Et] 
118f [R = Me] 
118g [R = nPr] 
118h [R = i-Pr] 
118i [R = Bn] 
118j [R = n-Bu] 























 isolated yield after 4 h; 
b 
determined by chiral HPLC.  Absolute Configuration was 
determined by independent synthesis, X-ray structure analysis of a 120 derivative. 
The main task to develop chiral catalysts which enables the preparation of products 
with highest enantiomeric excess is in line with the requirement of the preparation of both 
enantiomers of a target.
31-33
  Traditional methods require both enantiomers as the chiral 
catalyst or ligand to achieve inversed enantiomers respectively.  Recent attentions have 
been driven to the usage of one chiral promoter to synthesize both enantiomers.  Besides, 
no example concerning the influence of remote double-bond geometry over the 
enantioselectivity of γ-selective allylic addition reactions was reported.  Thus, the effect 
of double bond geometry of the conjugated enolates in this bicyclic guanidine catalyzed 
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allylic γ-amination reactions drew great attention to us because it indicated the usefulness 
of this methodologies for further synthetic applications.   
Chart 3.1 γ-Selective direct allylic amination of (Z)-β,γ-unsaturated acetyl-
oxazolidinethiones with di-tert-butyl azodicarboxylate. 
a 
isolated yield after 36 h; 
b
determined by chiral HPLC.  
c
MTBE, -50 °C, isolated yield 
after 4 h; 
d
Hexane, rt, isolated yield after 36 h. 
In order to achieve the opposite enantiomer, we decided to synthesize the (Z)-β,γ-
unsaturated thioesters for the bicyclic guanidine catalyzed allylic γ-amination reactions.  
Preliminary study using (Z)-β,γ-unsaturated 1-napthylene thioester 121f offered moderate 
enantioselectivity (77% ee).  Substitution the 1-napthylene thioester with 4-tert-butyl 
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phenyl thioester 121d and 2-napthylene thioester 121e did not affect enantioselectivity 
significantly.  Again, the aliphatic thioesters 121a-c, which show poor enantioselectivity 
control for the (E)-β,γ-unsaturated 1-naphthyl thioesters, offered moderate 
enantioselectivity level.  β-Keto acetyloxazolidinone, which shows better 
enantioselectivity control due to the additional hydrogen bonding of the carbonyl group 
compared with the ester group, were successful in the previous reported asymmetric 
Mannich reactions.
34
  When the thioester group was replaced with 4,4-dimethyl-2-
oxazolidinone, reaction rate was too slow to be observed.  However, subtle replacement 
of the 4,4-dimethyl-2-oxazolidinone with 4,4-dimethyloxazolidine-2-thione ring led to 
significant enhancement of the reaction rate and better enantioselectivity (Chart 1, 122g-
i).  Up to 92% ee and good yield were observed.  The limited scope of the substrates was 
due to the shortage of the commercially available 3-pentyn-1-ol derivatives.  Novel 
method to synthesize the (Z)-β,γ-unsaturated acetyloxazolidinethiones is under 
development. 
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By simple modification the thioester and acetyloxazolidinethione moiety under mild 
reaction condition, the inversed enantiomers were obtained with good yield and 
enantioselectivity.  The competing addition of methanol to the C-S double led to the 
deteriorated yield for the esterification of 122b (Eq. 5).  The HPLC spectras of the two 
enantiomers were compared, from where the opposite enantio- configurations are clearly 
represented.  The absolute configuration of the products was established by chemical 
transformation to the hydrazine derivatives, which was able to form crystals for X-ray 





The γ-selective allylic amination products have a broad potential of synthetic 
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applications based on two aspects: the enantio- controllable chiral center and the easily 
modifiable double bond next to it. g-Aminobutyric acid (GABA), first isolated in brain 
tissue in 1950, was revealed to play a vital role as the major inhibitory neurotransmitter in 
the central nervous system.
35
  Studies of the enantiomers of 4-methyl-GABA revealed 
that these compounds display different stereoselectivity in neuronal GABA uptake and 
GABAA receptor binding.  Thus, we managed to synthesize enantio pure g-aminobutyric 
acid 125 derivative by one step reduction of the double bond and cleavage of the N-N 
single bond (Eq. 6).  This methodology can be applied to synthesize a series of acyclic 
GABA derivatives, which is applicable to both enantiomers.   
On the other hand, construction of three consecutive chiral centers was fulfilled in this 
reaction.  (+)-Zwittermicin A 128, a water-soluble natural antibiotic which was isolated 
from fermentation of the soil-borne bacterium Bacillus cereus, is of significant interest 
for control of crop diseases both as an antifungal agent and an adjuvant with BT toxin for 
biocontrol.
36
  We can achieve the core structure of (+)-Zwittermicin A by OsO4 promoted 
high diastereoselective dihydroxylation near the chiral amino group (Eq. 7) and cleavage 
of the N-N bond afterwards.   
In summary, we have successfully developed a bicyclic guanidine catalyzed γ-selective 
allylic amination reaction.  Both enantiomers with excellent enantioselectivity can be 
obtained.  The computational study revealed the possible origin of the inversed 
enantioselectivity and diastereoselectivity.  This methodology was elegantly utilized in 
the synthesis of biologically and pharmaceutically important g-Aminobutyric acid 
derivatives and (+)-Zwittermicin A derivatives, which is applicable to both enantiomers. 
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4.1 General Information. 
4.1.1 General Procedures and Methods. 
 
Experiments involving moisture and/or air sensitive components were 
performed under a positive pressure of nitrogen in oven-dried glassware 
equipped with a rubber septum inlet. Air sensitive reagents were weighed in a 
glovebox. Dried solvents and liquid reagents were transferred by oven-dried 
syringes or hypodermic syringe cooled to ambient temperature in a desiccator. 
Reactions mixtures were stirred in 50 mL round bottle flasks or test tubes with 
Teflon-coated magnetic stirring bars unless otherwise stated. Moisture in 
non-volatile reagents/compounds was removed in high vacuo by means of an 
oil pump and subsequent purging with nitrogen. Solvents were removed in 
vacuo under ~30 mmHg and heated with a water bath at 33 °C using Heidolph 
or Büchi rotary evaporator with Eyela A-3S aspirator. The condenser was 
cooled with running water at 0 °C. 
Reactions requiring temperatures −20 °C or below were stirred in either 
Thermo Neslab CB-60 with Cryotrol temperature controller or Eyela PSL-1400 
with digital temperature controller cryobaths. HPLC grade isopropanol was 
used as the bath medium.  
All experiments were monitored by analytical thin layer chromatography 
(TLC). TLC was performed on pre-coated plates, Merck 60 F254. After elution, 







Further visualization was achieved by staining KMnO4, ceric molybdate, or 
anisaldehyde solution. For those using the aqueous stains, the TLC plates were 
heated on a hot plate.     
Columns for flash chromatography (FC) contained silica gel 60 (0.040 mm 
- 0.063 mm, Merck). Columns were packed as slurry of silica gel in hexane and 
equilibrated with the appropriate solvent/solvent mixture prior to use. The 
analyte was loaded neat or as a concentrated solution using the appropriate 
solvent system. The elution was assisted by applying pressure of about 2 atm 




Proton nuclear magnetic resonance (
1





P NMR), and fluorine NMR (
19
F NMR) spectra were 
recorded in CDCl3 otherwise stated. 
1
H (500 MHz or 300 MHz), 
13
C (125 MHz 
or 75 MHz) with complete proton decoupling, 
31
P (202 MHz) with complete 
proton decoupling, and 
1
H Nuclear Overhauser Effect (NOE) NMRs were 
performed on a 500 MHz Bruker AMX NMR spectrometer. 
19
F NMR (282 
MHz) was performed on a 300 MHz Bruker ACF spectrometer. Chemical shifts 
were reported as δ in units of parts per million (ppm) downfield from 
tetramethylsilane (δ 0.00), using the residual solvent signal as an internal 
standard: CDCl3 (
1






Multiplicities were given as: s (singlet), d (doublet), t (triplet), q (quartet), 
quintet, m (multiplets), dd (doublet of doublets), dt (doublet of triplets), and br 
(broad). Coupling constants (J) were recorded in Hertz (Hz). The number of 
proton atoms (n) for a given resonance was indicated by nH. The number of 
carbon atoms (n) for a given resonance was indicated by nC. High resolution 
Fast Atom Bombardment (FAB) and Electron Impact (EI) mass spectra were 
performed by Chemical and Molecular Analysis Centre (CMAC) of the 
National University of Singapore. They were obtained on a Finnigan/MAT 
95XL-T and Micromass VG7035 double focusing mass spectrometer of high 
resolution. High resolution Electrospray Ionization (ESI) mass spectra were 
obtained on a Shimadzu LCMS-IT-TOF spectrometer including an SPD-M20A 
prominence PDA detector, CBM-20A prominence communication bus module, 
CTO-20A prominence column oven, SIL-20AC prominence auto sampler, 
DGU-20A3 prominence degasser and LC-20AD prominence liquid 
chromatograph. Shimadzu Formula Predictor Software was used to process the 
data. MS and HRMS were reported in units of mass of charge ratio (m/z). Mass 
samples were dissolved in CH3CN (HPLC Grade) unless otherwise stated. 
Infrared spectra (IR) were recorded by dissolving samples in CHCl3 and spread 
as a thin film on NaCl cells unless otherwise stated. BIO-RAD Excalibur 
FTS3000 FTIR spectrometer was used to record the IR spectra. Optical 







of wavelength 589 nm and reported as follows; CT  ][  (c = g/100 mL, 
solvent). Melting points were determined on a BÜCHI B-540 melting point 
apparatus.  
Enantiomeric excesses were determined by chiral High Performance Liquid 
Chromatography (HPLC) analysis on Dionex HPLC UltiMate
®
 3000 series, 
including a variable wavelength UV/VIS detector VWD-3400 and LPG-3400A 
pump with manual injection valve. Data acquisitions were done using 
Chromeleon
®
 software. HPLC samples were dissolved in HPLC grade 




All commercial reagents were purchased from Sigma-Aldrich, Fluka, Alfa 
Aesar, Merck, TCI, and Acros of the highest purity grade. They were used 
without further purification unless specified. All solvents used, mainly hexane 
(Hex) and ethyl acetate (EtOAc), were distilled. Anhydrous DCM was freshly 
distilled from CaH2. Anhydrous THF was freshly distilled from 
Na/benzophenone. MeCN and CHCl3 were distilled from CaH2. Anhydrous 
hexane was purchased from Sigma-Aldrich. All compounds synthesized were 
stored in a −20 °C freezer and light-sensitive compounds were protected with 
aluminium foil. Catalyst 1b was synthesized previously by our group with 






of solid K2CO3 and subsequent re-crystallized from hexane. 
4.2 Preparation and Characterization of Substrates & Products.  
4.2.1 Representative Procedure for Synthesis of 2-Methylene-N-aryl 
























    Maleic anhydride (0.98 g, 10.00 mmol, 1.00 equiv.) was dissolved in 
CH2Cl2 (8.00 mL) in a 25 mL roundbottomed flask with stirring. When all the 
maleic anhydride was dissolved, the 3, 5-difluoroaniline (1.29 g, 10.00 mmol, 
1.00 equiv.) was added dropwise and the mixture stirred over an hour. The 
solvent was removed in vacuo. Acetic anhydride (3.30 mL, 35 mmol, 3.50 
equiv.) and NaOAc (328 mg, 4 mmol, 0.40 equiv.) were added to the 
round-bottomed flask equipped with a glass stopper. The reaction mixture was 
refluxed for 40 minutes. The crude reaction mixture was diluted with water (50 
mL) and extracted with ethyl acetate (3 × 40 mL).  
 
    129 (1.045 g, 5.00 mmol, 1.00 equiv.) was dissolved in HOAc (4.00 mL) 
in a 25 mL round bottomed flask with stirring.  Triphenylphosphine (1.31 g, 
5.00 mmol, 1.00 equiv.) and paraformaldehyde (0.75 g, 25.00 mmol, 5.00 
equiv.) were added and the mixture was refluxed for 40 minutes. The crude 
reaction mixture was diluted with water (50 mL) and extracted with ethyl 
acetate (3 × 40 mL).  The organic layer was washed with brine and dried over 







flash column chromatography yielded the product 77. 
1
H NMR (300 MHz, 
CDCl3, ppm): δ = 7.24 (m, 2H), 6.81 (m, 1H), 6.51 (t, J = 2.5 Hz, 1H), 5.79 (t, 
J = 2.1 Hz, 1H), 3.5 (m, 2 H);  
13
C NMR (75.5 MHz, CDCl3, ppm): δ = 172.6, 
167.9, 133.3, 132.8, 130.3, 128.8, 126.9, 121.1, 33.9;  
19
F NMR (282.4 MHz, 
CDCl3, ppm): -32.3;   LRMS (ESI) m/z 222.0 (M - H)-. 
 
60% yield. white solid;  
1
H NMR (300 MHz, CDCl3, ppm): δ = 7.49 (d, J 
=8.8 Hz, 2H), 7.34 (d, J = 8.8 Hz, 2H), 6.51 (t, J = 2.5 Hz, 1H), 5.79 (t, J = 2.1 
Hz, 1H), 3.54 (t, J = 2.3 Hz, 2H);  
13
C NMR (75.5 MHz, CDCl3, ppm): δ = 
172.4, 168.1, 134.3, 132.6, 130.2, 129.2, 127.5, 122.1, 33.8; LRMS (ESI) m/z 
220.3 (M - H)-. 
      
60% yield. yellow solid;  
1
H NMR (300 MHz, CDCl3, ppm): δ = 7.28 (d, J 
=9.08 Hz, 2H), 7.03 (d, J = 9.04 Hz, 1H), 6.49 (t, J = 2.5 Hz, 1H), 5.76 (t, J = 
2.1 Hz, 1H), 3.86 (s, 3H), 3.53 (t, J = 2.3 Hz, 2H); 
13
C NMR (75.5 MHz, 
CDCl3, ppm): δ = 173.0, 168.6, 159.4, 132.9, 127.5, 124.4, 121.5, 114.4, 55.4, 







60% yield. white solid;  
1
H NMR (300 MHz, CDCl3, ppm): δ = 8.03 (d, J 
=7.19 Hz, 1H), 7.99 (d, J = 1.82 Hz, 1H), 7.63 (t, J = 7.05 Hz, 2H), 6.53 (t, J = 
2.5 Hz, 1H), 5.83 (t, J = 2.1 Hz, 1H), 3.59 (t, J = 2.3 Hz, 2H), 2.62 (s, 3H);  
13
C NMR (75.5 MHz, CDCl3, ppm): δ = 196.7, 172.4, 168.1, 138.0, 132.6, 
130.7, 129.4, 128.2, 126.3, 122.1, 33.9, 26.6; LRMS (ESI) m/z 228.3 (M - H)-. 
 
4.2.2 Representative Procedure for Synthesis of Benzylidene-N-aryl 
Succinimides.                                 
 
Benzyl aldehyde (200 mg, 1.38 mmol, 1.0 equiv.), 129 (288 mg, 1.38 mmol, 
1.0 equiv.), triphenylphosphine (361 mg, 1.38 mmol, 1.0 equiv.), were 
dissolved in anhydrous DCM (5 mL) with stirring for 24 hs.  The solvent was 
removed in vacuo and purification of the crude product by flash column 
chromatography yielded the product 85a as white solid.  High 
diastereoselectivity ( >99:1) was obtained based on 
1
H NOE result.  
1
H NMR 
(300 MHz, CDCl3, ppm): δ = 7.77 (t, J = 2.40 Hz, 1H), 7.76-7.47 (m, 5H), 7.08 
(dd, J = 2.30, 7.70 Hz, 2H), 6.90 (m, 1H), 3.59 (t, J = 2.4 Hz, 2H);  
13
C NMR 
(75.5 MHz, CDCl3, ppm): δ = 172.1, 169.1, 164.5 (d, J = 13.8 Hz), 160.9 (d, J 
= 13.8 Hz), 136.3, 133.8, 133.7, 130.6, 129.2, 122.1, 109.9, 109.7, 104.2 (t, J = 
25.3 Hz), 34.1;  
19
F NMR (282.4 MHz, CDCl3, ppm): -32.2 (t, J = 7.54 Hz);   
LRMS (ESI) m/z 298.4 (M - H)-. 
 
65% yield. white solid;  
1







2.2 Hz, 1H), 7.99 (s, 1H), 7.76-7.45 (m, 5H), 3.79 (t, J = 2.2 Hz, 2H), 2.62 (s, 
3H);  
13
C NMR (75.5 MHz, CDCl3, ppm): δ = 196.8, 172.7, 169.7, 138.0 (d, J 
= 13.8 Hz), 160.9 (d, J = 13.8 Hz), 136.3, 133.8, 133.7, 130.6, 129.2, 122.1, 
109.9, 109.7, 104.2 (t, J = 25.3 Hz), 34.1;  LRMS (ESI) m/z 298.4 (M - H)-. 
 
70% yield. white solid; 
1
H NMR (300 MHz, CDCl3, ppm): δ = 7.73 (s, 1H), 
7.99 (s, 1H), 7.55-7.46 (m, 5H), 7.31 (d, J = 8.8 Hz, 2H), 7.02 (d, J = 8.8 Hz, 
2H), 3.84 (s, 3H), 3.75 (d, J = 2.2 Hz, 2H);  
13
C NMR (75.5 MHz, CDCl3, 
ppm): δ = 173.2, 170.3, 159.4, 135.2, 134.1, 130.2, 129.1, 127.6, 124.6, 123.1, 
114.5, 55.5, 34.1;  LRMS (ESI) m/z 292.4 (M - H)-. 
 




    Ethyl glyoxalate (140 mg, 1.38 mmol, 1.0 equiv.), phenyl maleimide (239 
mg, 1.38 mmol, 1.0 equiv.), triphenylphosphine (361 mg, 1.38 mmol, 1.0 
equiv.), were dissolved in anhydrous DCM (5 mL) with stirring for 24 hs.  
The solvent was removed in vacuo and purification of the crude product by 
flash column chromatography yielded the product 87a as white solid.  High 
diastereoselectivity (>99:1) was obtained based on 
1
H NOE result.  
1
H NMR 
(300 MHz, CDCl3, ppm): δ = 7.50-7.31 (m, 5H), 6.91 (t, J = 2.65 Hz, 1H), 4.35 








NMR (75.5 MHz, CDCl3, ppm): δ = 172.5, 167.9, 164.7, 139.7, 131.4, 129.1, 
128.8, 126.1, 123.1, 61.4, 34.4, 14.1;  LRMS (ESI) m/z 258.3 (M - H)-. 
 
70% yield. white solid;  
1
H NMR (300 MHz, CDCl3, ppm): δ = 7.49-7.30 (m, 
5H), 6.87 (s, 1H), 5.16 (m, 1H), 3.83 (d, J = 2.3 Hz, 2H), 1.32 (d, J = 6.26 Hz, 
6H);  
13
C NMR (75.5 MHz, CDCl3, ppm): δ = 172.5, 168.0, 164.2, 139.4, 
131.5, 129.2, 128.8, 126.2, 123.7, 69.2, 34.5, 21.8;  LRMS (ESI) m/z 272.3 
(M - H)-. 
 
70% yield. white solid;  
1
H NMR (300 MHz, CDCl3, ppm): δ = 7.49-7.30 (m, 
5H), 6.86 (s, 1H), 3.85 (d, J = 2.3 Hz, 2H), 1.58 (s, 9H);  
13
C NMR (75.5 
MHz, CDCl3, ppm): δ = 172.4, 168.0, 164.2, 139.3, 131.4, 129.1, 128.7, 126.2, 
123.7, 69.2, 34.5, 21.7;  LRMS (ESI) m/z 286.2 (M - H)-. 
 
4.2.4 Typical Experimental Procedure for the Reaction between 
2-Methylene-N-aryl Succinimides 77 and N-3-Ethylpentan-3-yloxy 




























    N-3-ethylpentan-3-yloxycarbonyl (Eoc) imine 83a (39.2 mg, 0.15 mmol, 
3.0 equiv.) and 65 (1.12 mg, 0.005 mmol, 0.1 equiv) were dissolved in 







2-methylene-N-(3,5-difluorophenyl) succinimide 77 (11.1 mg, 0.05 mmol, 1.0 
equiv.) was added. The reaction mixture was stirred at room temperature and 
monitored by TLC. After 24 hours, upon complete consumption of 77, the 
reaction solvent was removed in vacuo and the crude product was directly 
loaded onto a short silica gel column, followed by gradient elution with 
hexane/EA mixtures (20/1-7/1 ratio). After removing the solvent, product 84d 
(22.2 mg) was obtained as colorless oil in 92% yield.  
 
Table 1. Solvent effect on direct allylation reaction of 2-methylene-N-aryl 

































1 Hexane 24 32 76 
2 Ethyl Acetate 24 55 49 
3 Acetone 24 -- -- 
4 THF 4 92 8 
5 Toluene 24 90 70 
6 DCM 24 90 77 




 determined by chiral HPLC. Polar solvents such as DMF, 







yellow oil; 86% ee;  [α]29D  = -72.9 (c 0.6, CHCl3);  
1
H NMR (500 MHz, 
CDCl3, ppm): δ = 7.55 (d, J = 8.7 Hz, 2H), 7.42 (d, J = 8.7 Hz, 2H), 7.39 (d, J 
= 8.0 Hz, 2H), 7.31 (d, J = 8.0 Hz, 2H), 6.10 (d, J = 8.31 Hz, 1H), 6.05 (d, J = 
8.31 Hz, 1H), 2.47 (s, 3H), 2.34 (s, 3H), 1.96 (q, J = 7.7 Hz, 6H), 0.95 (t, J = 
7.7 Hz, 9H);  
13
C NMR (75.5 MHz, CDCl3, ppm): δ = 169.9, 154.8, 138.5, 
138.1, 137.8, 135.6, 133.2, 130.0, 129.8, 129.1, 127.5, 126.9, 126.7, 126.4, 
87.9, 50.6, 27.0, 21.0, 9.1, 7.6;  IR (film): 2964, 2932, 2860, 1716, 1683, 1653, 
1558 cm
-1
;  LRMS (ESI) m/z 505.0 (M + Na
+
), HRMS (ESI) m/z 505.1886 
(M + Na
+




Na 505.1865.  The ee was determined 
by HPLC analysis. CHIRALCEL IC (4.6 mm i.d. x 250 mm); 
Hexane/2-propanol = 95/5; flow rate 0.5 ml/min; 25°C; 230 nm; retention time: 
21.2 min, 35.5 min. 
 
Yellow oil; 84% ee; [α]29D  = -118.0 (c 0.6, CHCl3);  
1
H NMR (500 MHz, 
CDCl3, ppm): δ = 7.26 (d, J = 8.0 Hz, 2H), 7.20 (d, J = 8.9 Hz, 2H), 7.16 (d, J 
= 8.0 Hz, 2H), 6.94 (d, J = 8.9 Hz, 2H), 6.06 (d, J = 8.6 Hz, 1H), 5.90 (d, J = 
8.8 Hz, 1H), 3.80 (s, 3H), 2.33 (s, 3H), 2.26 (s, 3H), 1.96 (q, J = 7.7 Hz, 6H), 
0.95 (t, J = 7.7 Hz, 9H);  
13
C NMR (75.5 MHz, CDCl3, ppm): δ =170.4, 158.9, 
154.7, 141.6, 141.0, 140.9, 140.5, 139.8, 138.0, 135.8, 134.7, 129.7, 127.2, 
126.4, 123.9, 114.4, 114.3, 87.8, 55.4, 50.4, 27.0, 21.0, 9.0, 7.6; IR (film): 2968, 
2938, 2879, 1712, 1699, 1558, 1514 cm
-1
;  LRMS (ESI) m/z 501.1 (M + Na
+
), 
HRMS (ESI) m/z 501.2259 (M + Na
+
), calc. for C28H34N2O5
23
Na 501.2260.  
The ee was determined by HPLC analysis. CHIRALCEL IA (4.6 mm i.d. x 250 







retention time: 14.4 min, 28.4 min. 
 
Yellow oil; 81% ee;  [α]29D  = -79.6 (c 0.63, CHCl3);  
1
H NMR (500 MHz, 
CDCl3, ppm): δ = 8.05 (d, J = 8.9 Hz, 2H), 7.7 (m, 3H), 7.41 (d, J = 8.2 Hz, 
2H), 7.32 (d, J = 8.2 Hz, 2H), 6.11 (q, J = 8.3 Hz, 1H), 2.74 (s, 3H), 2.47 (s, 
3H), 2.37 (s, 3H), 1.96 (q, J = 7.7 Hz, 6H), 0.95 (t, J = 7. Hz, 9H); 
13
C NMR 
(75.5 MHz, CDCl3, ppm): δ = 196.9, 169.9, 154.8, 138.6, 138.2, 137.9, 135.5, 
131.9, 130.0, 129.8, 129.3, 127.2, 126.4, 125.5, 88.0, 50.6, 27.0, 26.6, 21.1, 9.0, 
7.6;  IR (film): 2964, 2931, 2879, 1716, 1699, 1558, 1506 cm
-1
;  LRMS (ESI) 
m/z 513.1, HRMS (ESI) m/z 513.2360 (M + Na
+
), calc. for C29H34N2O5
23
Na 
513.2360.  The ee was determined by HPLC analysis. CHIRALCEL AD (4.6 
mm i.d. x 250 mm); Hexane/2-propanol = 90/10; flow rate 1.0 ml/min; 25°C; 
230 nm; retention time: 23.5 min, 29.5 min. 
 
yellow oil; 87% ee;  [α]29D  = –80.0 (c 1.42, CHCl3);  
1
H NMR (500 MHz, 
CDCl3, ppm): δ = 7.26 (d, J = 8.1 Hz, 2H), 7.18 (d, J = 8.1 Hz, 2H), 7.24 (m, 
2H), 6.81 (m, 1H), 5.90 (m, 2H), 2.33(S, 3H), 2.23 (s, 3H), 1.96 (q, J = 7.7 Hz, 
6H), 0.95 (t, J = 7.7 Hz, 9H); 
13






163.4(d, J = 14.0 Hz), 160.0 (d, J = 14.0 Hz), 153.7, 137.7, 137.2, 136.9, 134.2, 
132.5, 128.8, 127.3, 125.4, 107.5 (q, J = 25.5 Hz), 102.3 (t, J = 25.5 Hz), 87.2, 
49.5, 26.0, 20.0, 8.1, 6.6;  
19
F NMR (282.4 MHz, CDCl3, ppm): 32.4 (S);  
IR (film): 2972, 2941, 2837, 1716, 1701, 1622, 1604, 1558 cm
-1
;  LRMS (ESI) 
m/z 507.0, 508.0, (M + Na
+
 ), HRMS (ESI) m/z 507.2056 (M + Na
+
), calc. for 
C27H30F2N2O5
23
Na 507.2066.  The ee was determined by HPLC analysis. 
CHIRALCEL IC (4.6 mm i.d. x 250 mm); Hexane/2-propanol = 80/20; flow 
rate 1.0 ml/min; 25°C; 230 nm; retention time: 15.9 min, 17.8 min. 
 
yellow oil; 77% ee;  [α]29D  = –76.8 (c 0.7, CHCl3);  
1
H NMR (500 MHz, 
CDCl3, ppm): δ = 7.76 (d, J = 8.5 Hz, 2H), 7.24 (d, J = 8.5 Hz, 2H), 7.03 (m, 
2H), 6.80 (m, 1H), 5.94 (m, 2H), 2.21 (s, 3H), 1.96 (q, J = 7.7 Hz, 6H), 0.95 (t, 
J = 7.7 Hz, 9H); 
13
C NMR (75.5 MHz, CDCl3, ppm): δ = 168.0, 163.5(d, J = 
13.9 Hz), 160.2(d, J = 13.9 Hz), 153.6, 137.5, 136.9, 136.4, 132.4, 131.3, 129.9, 
127.1, 121.4, 107.5(q, J = 25.5 Hz), 102.3 (t, J = 25.5 Hz), 87.4, 49.1, 26.0, 8.2, 
6.6;  
19
F NMR (282.4 MHz, CDCl3, ppm): 32.2 (t, J = 7.5 Hz);  IR (film): 
2976, 2941, 2881, 1716, 1701, 1635, 1604, 1558 cm
-1
;  LRMS (ESI) m/z 
570.9, 572.9, 573.9 (M + Na
+
), HRMS (ESI) m/z 573.11 (M + Na
+





Na 573.0994.  The ee was determined by HPLC analysis. 
CHIRALCEL IA (4.6 mm i.d. x 250 mm); Hexane/2-propanol = 90/10; flow 









yellow oil; 77% ee;  [α]29D  = –55.3 (c 1.5, CHCl3);  
1
H NMR (500 MHz, 
CDCl3, ppm): δ = 7.36 (m, 5H), 7.05 (m, 2H), 6.77 (m, 1H), 5.94 (m, 2H), 2.21 
(s, 3H), 1.96 (q, J = 7.7 Hz, 6H), 0.95 (t, J = 7.7 Hz, 9H); 
13
C NMR (75.5 MHz, 
CDCl3, ppm): δ = 168.0, 163.5(d, J = 13.9 Hz), 160.2 (d, J = 13.9 Hz), 153.6, 
137.5, 136.9, 135.9, 133.3, 132.5, 132.4, 129.9, 128.3, 126.8, 107.5 (q, J = 25.5 
Hz), 102.3 (t, J = 25.5 Hz), 87.4, 49.1, 26.0, 8.2, 6.6;  
19
F NMR (282.4 MHz, 
CDCl3, ppm): 32.2 (t, J = 7.5 Hz);  IR (film): 2972, 2941, 2864, 1716, 1683, 
1653, 1558, 1506  cm
-1
;  LRMS (ESI) m/z 526.9, 528.9 (M + Na
+
), HRMS 
(ESI) m/z 527.1537 (M + Na
+




Na 527.1520.  
The ee was determined by HPLC analysis. CHIRALCEL IA (4.6 mm i.d. x 250 
mm); Hexane/2-propanol = 90/10; flow rate 1.0 ml/min; 25°C; 230 nm; 
retention time: 6.7 min, 7.6 min. 
 
yellow oil; 83% ee;  [α]29D  = –30.2 (c 1.25, CHCl3);  
1
H NMR (500 MHz, 
CDCl3, ppm): δ = 7.44 (m, 5H), 7.07 (m, 2H), 6.81 (m, 1H), 5.94 (m, 2H), 2.23 
(s, 3H), 1.96 (q, J = 7.7 Hz, 6H), 0.95 (t, J = 7.7 Hz, 9H); 
13
C NMR (75.5 MHz, 






137.5, 137.2, 132.7, 132.5, 128.2, 127.3, 125.4, 107.5 (q, J = 25.5 Hz), 102.3 (t, 
J = 25.5 Hz), 87.2, 49.7, 26.0, 8.1, 6.6;  
19
F NMR (282.4 MHz, CDCl3, ppm): 
32.4 (S);  IR (film): 2970, 2941, 2860, 1716, 1701, 1683, 1653, 1558  cm-1;  
LRMS (ESI) m/z 469.27, 470.27 (M + ), HRMS (ESI) m/z 493. 1926 (M + 
Na
+
), calc. for C26H28F2N2O4
23
Na 493.1909.  The ee was determined by 
HPLC analysis. CHIRALCEL IC (4.6 mm i.d. x 250 mm); Hexane/2-propanol 
= 90/10; flow rate 1.0 ml/min; 25°C; 230 nm; retention time: 5.6 min, 6.7 min. 
 
yellow oil; 87% ee;  [α]29D  = –136.8 (c 1.13, CHCl3);  
1
H NMR (500 MHz, 
CDCl3, ppm): δ = 7.28 (d, J = 8.5 Hz, 2H), 7.04 (m, 2H), 6.89 (d, J = 8.5 Hz, 
2H), 6.81 (m, 1H), 3.79 (s, 3H), 2.21 (s, 3H), 1.96 (q, J = 7.7 Hz, 6H), 0.95 (t, 
J = 7.8 Hz, 9H); 
13
C NMR (75.5 MHz, CDCl3, ppm): δ = 169.4, 164.5 (d, J = 
14.2 Hz), 161.2 (d, J = 14.1 Hz), 154.7, 138.8, 137.7, 133.6, 131.9, 130.2, 
127.8, 108.5 (q, J = 25.5 Hz), 103.2 (t, J = 25.5 Hz), 88.1, 55.3, 50.4, 27.0, 9.1, 
7.6;  
19
F NMR (282.4 MHz, CDCl3, ppm): 32.4 (S);  IR (film): 2972, 2941, 
2837, 1716, 1701, 1622, 1604, 1558  cm
-1
;  LRMS (ESI) m/z 523.0, 524.0 
(M + ), HRMS (ESI) m/z 523.2037 (M + Na
+
), calc. for C27H30F2N2O5
23
Na 
523.2015.  The ee was determined by HPLC analysis. CHIRALCEL IA (4.6 
mm i.d. x 250 mm); Hexane/2-propanol = 95/5; flow rate 0.5 ml/min; 25°C; 








yellow oil; 82% ee;  [α]29D  = –61.4 (c 12.9, CHCl3);  
1
H NMR (500 MHz, 
CDCl3, ppm): δ = 7.36 (dd, J = 5.2, 8.7 Hz, 2H), 7.23 (m, 4H), 6.81 (m, 1H), 
5.95 (m, 2H), 2.24 (s, 3H), 1.96 (q, J = 7.7 Hz, 6H), 0.95 (t, J = 7.8 Hz, 9H); 
13
C NMR (75.5 MHz, CDCl3, ppm): δ = 169.2, 164.5 (t, J = 14.0 Hz), 161.0 (t, 
J = 14.0 Hz), 154.7, 138.3, 134.2, 133.4, 128.3 (d, J = 8.3 Hz), 116.3 (d, J = 
21.7 Hz), 107.5 (q, J = 25.5 Hz), 102.3 (t, J = 25.5 Hz), 88.4, 50.1, 27.0, 9.1, 
7.6;  
19
F NMR (282.4 MHz, CDCl3, ppm): 32.4 (t, J = 14.0 Hz), -37.4;  IR 
(film): 2972, 2943, 2881, 1716, 1697, 1653, 1604, 1558 cm
-1
;  LRMS (ESI) 
m/z 511.1, (M + Na
+
 ), HRMS (ESI) m/z 511.1801 (M + Na
+
), calc. for 
C26H27F3N2O4
23
Na 511.1815.  The ee was determined by HPLC analysis. 
CHIRALCEL IC (4.6 mm i.d. x 250 mm); Hexane/2-propanol = 95/5; flow rate 
0.5 ml/min; 25°C; 230 nm; retention time: 15.2 min, 17.5 min. 
 
yellow oil; 81% ee;  [α]29D  = –115.7 (c 12.6, CHCl3);  
1
H NMR (500 MHz, 
CDCl3, ppm): δ = 7.87 (m, 4H), 7.51 (m, 3H), 7.05 (m, 2H),   6.79 (m, 1H), 
6.13 (m, 2H), 2.24 (s, 3H), 1.96 (q, J = 7.7 Hz, 6H), 0.95 (t, J = 7.8 Hz, 9H); 
13






J = 14.0 Hz), 154.8, 138.4, 135.6, 133.6, 133.3, 133.0, 128.0, 127.7, 126.7, 
125.5, 124.1, 108.5 (q, J = 25.5 Hz), 103.3 (t, J = 25.5 Hz), 88.2, 50.9, 27.0, 
9.2, 7.6;  
19
F NMR (282.4 MHz, CDCl3, ppm): 32.4;  IR (film): 2972, 2941, 
2837, 1716, 1701, 1653, 1635, 1616, 1558  cm
-1
;  LRMS (ESI) m/z 543.0, 
(M + Na
+
 ), HRMS (ESI) m/z 543.2091 (M + Na
+
), calc. for 
C30H30F2N2O4
23
Na 543.2066.  The ee was determined by HPLC analysis. 
CHIRALCEL AD (4.6 mm i.d. x 250 mm); Hexane/2-propanol = 95/5; flow 
rate 0.5 ml/min; 25°C; 230 nm; retention time: 23.0 min, 25.8 min. 
 
4.2.5 Typical Experimental Procedure for the Reaction between 
Benzylidene-N-aryl Succinimide 85a and N-3-Ethylpentan-3-yloxy 





























    N-3-ethylpentan-3-yloxycarbonyl (Eoc) imine 83a (39.2 mg, 0.15 mmol, 
3.0 equiv.) and 65 (1.12 mg, 0.005 mmol, 0.1 equiv) were dissolved in DCM 
(0.5 mL) and stirred at room temperature for 10 min, then 
benzylidene-N-(3,5-difluorophenyl) succinimide 85a (14.9 mg, 0.05 mmol, 1.0 
equiv.) was added. The reaction mixture was stirred at room temperature and 
monitored by TLC. After 24 hours, upon complete consumption of 85a, the 
reaction solvent was removed in vacuo and the crude product was directly 
loaded onto a short silica gel column, followed by gradient elution with 
hexane/EA mixtures (20/1-7/1 ratio). After removing the solvent, product 86a 









white solid; 85% ee, dr: 99:1;  [α]29D  = +167.3 (c 1, CHCl3);  
1
H NMR (500 
MHz, CDCl3, ppm): δ = 7.82 (d, J = 7.5 Hz, 2H), 7.71 (s, 1H), 7.58 – 7.51 (m, 
3H),   7.04 (d, J = 7.8 Hz, 2H), 6.87 (d, J = 7.8 Hz, 2H), 6.82 (m, 1H), 6.50 
(d, J = 5.5 Hz, 2H), 6.16 (d, J = 9.0 Hz, 1H), 5.38 (dd, J = 9.0, 3.7 Hz, 1H), 
4.47 (s, 1H), 2.28 (s, 3H), 1.84 (q, J = 7.7 Hz, 6H), 0.88 (t, J = 7.8 Hz, 9H); 
13
C 
NMR (75.5 MHz, CDCl3, ppm): δ = 174.2, 168.5, 164.4, 161.1, 154.5, 138.4, 
137.9, 133.2, 132.8, 131.2, 130.9, 129.6, 129.2, 126.6, 124.0, 110.2, 109.8, 
87.7, 52.8, 48.9, 27.0, 20.9, 7.7;  
19
F NMR (282.4 MHz, CDCl3, ppm): 32.4;  
IR (film): 2970, 2939, 2864, 1716, 1683, 1653, 1558  cm
-1
;  LRMS (ESI) 
m/z 583.0, 584.1, (M + Na
+
 ), HRMS (ESI) m/z 583.2393 (M + Na
+
), calc. for 
C33H34F2N2O4
23
Na 583.2397.  The ee was determined by HPLC analysis. 
CHIRALCEL IA (4.6 mm i.d. x 250 mm); Hexane/2-propanol = 80/20; flow 
rate 1.0 ml/min; 25°C; 230 nm; retention time: 7.3 min, 8.9 min (major 
isomer). 
   








(500 MHz, CDCl3, ppm): δ = 7.94 (d, J = 7.9 Hz, 2H), 7.82 (d, J = 7.5 Hz, 2H), 
7.77 (s, 1H), 7.59 - 7.49 (m, 5H), 7.44 (s, 1H), 7.06 (d, J = 7.8 Hz, 2H), 6.91 (d, 
J = 7.8 Hz, 2H), 6.24 (d, J = 9.0 Hz, 1H), 5.40 (dd, J = 9.0, 3.7 Hz, 1H), 4.49 (s, 
1H), 2.57 (s, 3H), 2.29 (s, 3H), 1.84 (q, J = 7.7 Hz, 6H), 0.88 (t, J = 7.7 Hz, 
9H); 
13
C NMR (75.5 MHz, CDCl3, ppm): δ = 196.5, 174.8, 169.0,  154.5, 
138.3, 138.0, 137.5, 133.4, 132.9, 131.9, 131.1, 130.9, 129.6, 129.3, 129.2, 
128.3, 126.8, 126.5, 124.4, 87.6, 52.7, 48.9, 27.0, 26.5, 21.0, 7.7;  IR (film): 
2970, 2939, 2879, 1712, 1651, 1558, 1506 cm
-1
;  LRMS (ESI) m/z 589.3, 
590.3, (M + Na
+
 ), HRMS (ESI) m/z 589.2669 (M + Na
+
), calc. for 
C35H38N2O5
23
Na 589.2673.  The ee was determined by HPLC analysis. 
CHIRALCEL IA (4.6 mm i.d. x 250 mm); Hexane/2-propanol = 80/20; flow 
rate 1.0 ml/min; 25°C; 230 nm; retention time: 19.4 min, 30.1 min (major 
isomer), 23.2, 37.6 min (minor isomer).  
 
 yellow oil; 83% ee, dr: 99:1;  [α]29D  = +129.0 (c 1.11, CHCl3);  
1
H NMR 
(500 MHz, CDCl3, ppm): δ = 7.80 (d, J = 7.5 Hz, 2H), 7.74 (s, 1H), 7.58 - 7.49 
(m, 3H), 7.44 (s, 1H), 7.03 (d, J = 7.7 Hz, 2H), 6.91 (dd, J = 7.7, 7.9 Hz, 2H), 
6.80 (d, J = 7.9 Hz, 1H), 6.32 (d, J = 9.0 Hz, 1H), 5.38 (dd, J = 9.0, 3.7 Hz, 
1H), 4.40 (s, 1H), 3.80 (s, 3H), 2.27 (s, 3H), 1.84 (q, J = 7.7 Hz, 6H), 0.88 (t, J 
= 7.8 Hz, 9H); 
13
C NMR (75.5 MHz, CDCl3, ppm): δ = 175.3, 169.5,  159.5, 
155.9, 154.5, 137.9, 136.8, 133.6, 133.0, 130.8, 130.6, 129.5, 128.9, 127.5, 
126.7, 124.7. 123.9, 114.2, 87.4, 55.4, 52.5, 48.6, 26.9, 20.9, 7.7;  IR (film): 
2966, 2937, 2860, 1766, 1705, 1647, 1514 cm
-1
;  LRMS (ESI) m/z 577.1, 
588.1, (M + Na
+
 ), HRMS (ESI) m/z 577.2698 (M + Na
+









Na 577.2698.  The ee was determined by HPLC analysis. 
CHIRALCEL IA (4.6 mm i.d. x 250 mm); Hexane/2-propanol = 90/10; flow 
rate 1.0 ml/min; 25°C; 230 nm; retention time: 21.4 min, 34.9 min (major 
isomer), 42.9 min (minor isomer).   
   
White solid; 78% ee, dr: 91:9;  [α]29D  = +175.1 (c 1.0, CHCl3);  
1
H NMR 
(500 MHz, CDCl3, ppm): δ = 7.81 (s, 1H), 7.76 (d, J = 7.3 Hz, 2H), 7.58 - 7.52 
(m, 3H), 7.37 (d, J = 8.4 Hz, 2H), 6.86 (m, 3H), 6.57 (d, J = 5.3 Hz, 2H), 6.27 
(d, J = 9.0 Hz, 1H), 5.38 (dd, J = 9.0, 3.7 Hz, 1H), 4.44 (s, 1H), 1.84 (q, J = 7.7 
Hz, 6H), 0.88 (t, J = 7.8 Hz, 9H); 
13
C NMR (75.5 MHz, CDCl3, ppm): δ = 
174.1, 168.1, 164.5 (J = 13.7 Hz ), 161.2 (J = 13.7 Hz ), 154.3, 138.5, 135.6, 
133.1, 132.9, 132.5, 131.9, 131.6, 130.8, 130.1, 129.8, 129.7, 129.3, 128.9, 
128.3, 123.4, 122.7, 109.9 (J = 27.0 Hz), 104.7 ( J = 25.0 Hz), 88.0, 52.2, 48.5, 
27.0, 7.7;  
19
F NMR (282.4 MHz, CDCl3, ppm): - 31.9, IR (film): 2966, 2929, 
2856, 1770, 1716, 1647, 1608, 1558 cm
-1
;  LRMS (ESI) m/z 647.1, 649.1, 
650.1, (M + Na
+
 ), HRMS (ESI) m/z 647.1336, 649.1334 (M + Na
+









Na  647.1327, 649.1307. The ee was 
determined by HPLC analysis. CHIRALCEL IA (4.6 mm i.d. x 250 mm); 
Hexane/2-propanol = 85/15; flow rate 1.0 ml/min; 25°C; 230 nm; retention 








White solid; 85% ee, dr: 99:1;  [α]29D  = +180.0 (c 0.46, CHCl3);  
1
H NMR 
(500 MHz, CDCl3, ppm): δ = 7.82 (d, J = 7.3 Hz, 2H), 7.78 (s, 1H), 7.59 - 7.51 
(m, 3H), 7.27 -7.23 (m, 3H),  6.99 (d, J = 7.1 Hz, 2H), 6.83 (m, 1H), 6.52 (d, 
J = 5.6 Hz, 2H), 6.23 (d, J = 9.0 Hz, 1H), 5.43 (dd, J = 9.0, 3.7 Hz, 1H), 4.48 (s, 
1H), 1.85 (q, J = 7.7 Hz, 6H), 0.87 (t, J = 7.7 Hz, 9H); 
13
C NMR (75.5 MHz, 
CDCl3, ppm): δ = 174.2, 168.4, 164.4 (J = 13.7 Hz ), 161.1 (J = 13.7 Hz ), 
154.5, 138.0, 136.3, 132.7, 131.2, 130.9, 129.6, 128.5, 126.7, 123.8, 110.1 (J = 
27.0 Hz), 104.6 ( J = 25.0 Hz), 87.8, 52.9, 48.9, 27.0, 7.7;  
19
F NMR (282.4 
MHz, CDCl3, ppm): - 32.3, IR (film): 2966, 2937, 2860, 1716, 1683, 1653, 
1616, 1558 cm
-1
;  LRMS (ESI) m/z 569.0, 570.0 (M + Na
+
 ), HRMS (ESI) 
m/z 569.2204 (M + Na
+
), calc. for C32H32N2O4F2
23
Na 569.2222.  The ee was 
determined by HPLC analysis. CHIRALCEL IA (4.6 mm i.d. x 250 mm); 
Hexane/2-propanol = 92/8; flow rate 0.8 ml/min; 25°C; 230 nm; retention time: 
17.1 min, 20.7 min (major isomer), 26.0, 32.9 min (minor isomer). 
  
yellow oil; 85% ee, dr: 99:1;  [α]29D  = +137.2 (c 1.65, CHCl3);  
1
H NMR 







(m, 3H), 6.91 (d, J = 8.5 Hz, 2H), 6.84 (m, 1H), 6.75 (d, J = 8.5 Hz, 2H), 6.57 
(d, J = 6.7 Hz, 2H), 6.21 (d, J = 9.0 Hz, 1H), 5.37 (dd, J = 9.0, 3.7 Hz, 1H), 
4.48 (s, 1H), 3.75 (s, 3H), 1.84 (q, J = 7.7 Hz, 6H), 0.87 (t, J = 7.7 Hz, 9H); 
13
C 
NMR (75.5 MHz, CDCl3, ppm): δ = 174.4, 168.5, 164.4 (J = 13.7 Hz ), 161.1 
(J = 13.7 Hz ), 159.7, 154.5, 137.9, 133.3, 132.7, 131.2, 130.9, 130.1, 129.6, 
128.3, 127.8, 124.0, 113.9, 110.1 (J = 27.0 Hz), 104.6 ( J = 25.0 Hz), 87.7, 55.2. 
52.4, 48.9, 27.0, 7.7;  
19
F NMR (282.4 MHz, CDCl3, ppm): - 32.3, IR (film): 
2966, 2937, 2841, 1716, 1705, 1647, 1604, 1558 cm
-1
;  LRMS (ESI) m/z 
579.0 (M + Na
+
 ) HRMS (ESI) m/z 577.2660 (M + Na
+
), calc. for 
C33H34N2O5F2
23
Na  577.2634.  The ee was determined by HPLC analysis. 
CHIRALCEL IA (4.6 mm i.d. x 250 mm); Hexane/2-propanol = 90/10; flow 
rate 1.0 ml/min; 25°C; 230 nm; retention time: 12.9 min, 16.5 min (major 
isomer), 11.1 min (minor isomer).  
  
White solid; 82% ee, dr: 87:13;  [α]29D  = +96.6 (c 0.99, CHCl3);  
1
H NMR 
(500 MHz, CDCl3, ppm): δ = 7.52 (d, J = 7.4 Hz, 2H), 7.43 (s, 1H), 7.31 - 7.29 
(m, 3H), 6.97 – 6.84 (m, 4H), 6.83 (m, 1H), 6.60 (d, J = 8.5 Hz, 2H),  6.27 (d, 
J = 9.0 Hz, 1H), 5.40 (dd, J = 9.0, 3.7 Hz, 1H), 4.40 (s, 1H), 1.84 (q, J = 7.7 Hz, 
6H), 0.87 (t, J = 7.7 Hz, 9H); 
13
C NMR (75.5 MHz, CDCl3, ppm): δ = 174.2, 
168.2, 164.4 (J = 13.7 Hz ), 160.1 (J = 13.7 Hz ), 154.3, 138.3, 132.5,  131.3, 
130.8, 129.6, 128.4, 128.3, 123.5, 115.6, 109.9 (J = 27.0 Hz), 104.3 ( J = 25.0 
Hz), 87.9, 52.0. 48.6, 27.0, 7.7;  
19






IR (film): 2972, 2941, 2837, 1716, 1701, 1622, 1604, 1558  cm
-1
;  LRMS 
(ESI) m/z 587.2 (M + Na
+
 ) HRMS (ESI) m/z 587.2311 (M + Na
+
), calc. for 
C32H31N2O4F3
23
Na  587.2313.  The ee was determined by HPLC analysis. 
CHIRALCEL IA (4.6 mm i.d. x 250 mm); Hexane/2-propanol = 92/8; flow rate 
0.8 ml/min; 25°C; 230 nm; retention time: 17.4 min, 21.1 min (major isomer), 
23.2, 35.9 min (minor isomer). 
 
yellow oil; 84% ee, dr: 99:1;  [α]29D  = +96.5 (c .99, CHCl3);  
1
H NMR (500 
MHz, CDCl3, ppm): δ = 7.71 (d, J = 7.4 Hz, 2H), 7.68 (s, 1H), 7.67 (m, 3H), 
7.57 (m, 3H), 7.55 (m, 3H), 7.06 (d, J = 8.5 Hz, 1H), 6.76 (m, 1H),  6.35 (m, 
3H), 5.60 (dd, J = 9.0, 3.7 Hz, 1H), 4.57 (s, 1H), 1.86 (q, J = 7.7 Hz, 6H), 0.87 
(t, J = 7.7 Hz, 9H); 
13
C NMR (75.5 MHz, CDCl3, ppm): δ = 174.4, 168.2, 
164.3 (J = 13.7 Hz ), 160.1 (J = 13.7 Hz ), 154.5, 138.1, 133.8,  133.1, 132.8, 
131.3, 130.8, 129.6, 128.4, 127.8, 127.7, 126.7, 126.5, 125.7, 124.5, 123.9, 
110.1 (J = 27.0 Hz), 104.3 ( J = 25.0 Hz), 87.8, 53.1, 48.8, 27.0, 7.7;  
19
F 
NMR (282.4 MHz, CDCl3, ppm): - 32.3, IR (film): 2968, 2939, 2879, 1766, 
1720, 1699, 1651, 1558 cm
-1
;  LRMS (ESI) m/z 619.0, 620.1 (M + Na
+
 ) 
HRMS (ESI) m/z 619.2355 (M + Na
+
), calc. for C36H34N2O4F2
23
Na  619.2379.  
The ee was determined by HPLC analysis. CHIRALCEL IA (4.6 mm i.d. x 250 
mm); Hexane/2-propanol = 90/10; flow rate 1.0 ml/min; 25°C; 230 nm; 









4.2.6 Typical Experimental Procedure for the Reaction between 
Esterlidene-N-aryl Succinimide 87a and N-3-Ethylpentan-3-yloxycarbonyl 

























    N-3-ethylpentan-3-yloxycarbonyl (Eoc) imine 83a (39.2 mg, 0.15 mmol, 
3.0 equiv.) and 65 (1.12 mg, 0.005 mmol, 0.1 equiv) were dissolved in DCM 
(0.5 ml) and stirred at room temperature for 10 min, then 
esterlidene-N-arylsuccinimide 87a (14.8 mg, 0.05 mmol, 1.0 equiv.) was added. 
The reaction mixture was stirred at room temperature and monitored by TLC. 
After 4 hours, upon complete consumption of 87a, the reaction solvent was 
removed in vacuo and the crude product was directly loaded onto a short silica 
gel column, followed by gradient elution with hexane/EA mixtures (20/1-7/1 
ratio). After removing the solvent, product 88a (25.3 mg) was obtained as 
colorless oil in 92% yield.  
   
White solid; 71% ee;  [α]29D  = -21.0 (c 2.29, CHCl3);  
1
H NMR (500 MHz, 
CDCl3, ppm): δ = 7.45 (t, J = 8.6 Hz, 2H), 7.42 (d, J = 7.8 Hz, 3H), 7.29 (d, J = 
8.0 Hz, 2H), 7.17 (d, J = 8.0 Hz, 2H), 5.97 (d, J = 8.5 Hz, 1H), 5.88 (d, J = 8.4 






1.86 (q, J = 7.7 Hz, 6H), 1.25 (t, J = 7.2 Hz, 2H),  0.87 (t, J = 7.7 Hz, 9H); 
13
C 
NMR (75.5 MHz, CDCl3, ppm): δ = 169.3, 168.3, 154.8, 140.9, 137.9, 134.9, 
133.8, 131.3, 129.7, 128.9, 127.8, 126.5, 125.7, 88.0, 61.8, 50.3, 29.0, 27.0, 
21.0, 13.9, 7.7;  IR (film): 2972, 2939, 2881, 1712, 1701, 1653, 1558 cm
-1
;  
LRMS (ESI) m/z 543.0, 544.1 (M + Na
+
 ) HRMS (ESI) m/z 543.2486 (M + 
Na
+
), calc. for C30H36N2O6
23
Na  543.2466.  The ee was determined by HPLC 
analysis. CHIRALCEL IC (4.6 mm i.d. x 250 mm); Hexane/2-propanol = 
80/20; flow rate 1.0 ml/min; 25°C; 230 nm; retention time: 10.2 min, 14.2 min. 
  
yellow oil; 80% ee;  [α]29D  = -10.4 (c 2.04, CHCl3);  
1
H NMR (500 MHz, 
CDCl3, ppm): δ = 7.45 (t, J = 7.8 Hz, 2H), 7.42 (d, J = 7.8 Hz, 3H), 7.28 (d, J = 
7.9 Hz, 2H), 7.17 (d, J = 7.9 Hz, 2H), 5.95 (d, J = 8.5 Hz, 1H), 5.89 (d, J = 8.4 
Hz, 1H), 5.04 (m, 2H),  3.67 (q, J = 16.6 Hz, 2H),  2.33 (s, 3H), 1.82 (q, J = 
7.7 Hz, 6H), 1.25 (t, J = 6.7 Hz, 6H),  0.87 (t, J = 7.7 Hz, 9H); 
13
C NMR (75.5 
MHz, CDCl3, ppm): δ = 169.3, 167.9, 154.8, 140.8, 138.0, 135.0, 133.9, 131.3, 
129.0, 127.8, 126.5, 125.7, 88.0, 69.6, 50.3, 29.4, 27.0, 21.6, 7.7;  IR (film): 
2974, 2941, 2881, 1712, 1701, 1622, 1598, 1558 cm
-1
;  LRMS (ESI) m/z 
557.0, 558.0 (M + Na
+
 ) HRMS (ESI) m/z 557.2639 (M + Na
+
), calc. for 
C31H38N2O6
23
Na  557.2622.  The ee was determined by HPLC analysis. 
CHIRALCEL IC (4.6 mm i.d. x 250 mm); Hexane/2-propanol = 80/20; flow 







   
White solid; 77% ee;  [α]29D  = -22.0 (c 1.49, CHCl3);  
1
H NMR (500 MHz, 
CDCl3, ppm): δ = 7.45 (t, J = 7.8 Hz, 2H), 7.42 (d, J = 7.8 Hz, 3H), 7.28 (d, J = 
7.9 Hz, 2H), 7.17 (d, J = 7.9 Hz, 2H), 5.94 (s, 2H), 3.64 (q, J = 16.6 Hz, 2H),  
2.33 (s, 3H), 1.82 (q, J = 7.7 Hz, 6H), 1.44 (s, 9H),  0.87 (t, J = 7.7 Hz, 9H); 
13
C NMR (75.5 MHz, CDCl3, ppm): δ = 169.5, 167.3, 154.8, 140.5, 137.9, 
135.1, 134.3, 131.3, 129.6, 128.9, 127.7, 126.5, 125.7, 87.9, 82.5,  50.3, 30.3, 
27.8, 27.0, 21.0, 7.7;  IR (film): 2972, 2939, 2879, 1734, 1716, 1683, 1653, 
1635, 1558 cm
-1
;  LRMS (ESI) m/z 571.1, 572.1 (M + Na
+
 ) HRMS (ESI) m/z 
571.2771 (M + Na
+
), calc. for C32H40N2O6
23
Na  571.2779.  The ee was 
determined by HPLC analysis. CHIRALCEL IA (4.6 mm i.d. x 250 mm); 
Hexane/2-propanol = 80/20; flow rate 1.0 ml/min; 25°C; 230 nm; retention 
time: 6.8 min, 8.5 min.        
  
yellow oil; 71% ee;  [α]29D  = -26.0 (c 0.71, CHCl3);  
1
H NMR (500 MHz, 
CDCl3, ppm): δ = 7.49 (d, J = 8.4 Hz, 2H), 7.45 (t, J = 7.8 Hz, 3H), 7.33 (d, J = 






16.6 Hz, 2H), 1.82 (q, J = 7.7 Hz, 6H), 1.25 (t, J = 6.7 Hz, 6H),  0.87 (t, J = 
7.7 Hz, 9H); 
13
C NMR (75.5 MHz, CDCl3, ppm): δ = 169.3, 167.8, 154.6, 
140.2, 137.2, 134.4, 132.0, 131.3, 129.0, 128.5, 128.3, 127.9, 126.7, 125.7, 
122.2, 88.4, 69.8, 49.8, 29.4, 27.0, 21.6, 7.7;  IR (film): 2974, 2939, 2881, 
1712, 1701, 1622, 1604, 1558  cm
-1
;  LRMS (ESI) m/z 621.0, 623.0, 624.0 
(M + Na
+
 ) HRMS (ESI) m/z 621.1582, 623.1552 (M + Na
+









Na 621.1571, 623.1550.  
The ee was determined by HPLC analysis. CHIRALCEL IA (4.6 mm i.d. x 250 
mm); Hexane/2-propanol = 90/10; flow rate 1.0 ml/min; 25°C; 230 nm; 
retention time: 10.5 min, 16.6 min. 
 
 yellow oil; 75% ee;  [α]29D  = -10.0 (c 1.12, CHCl3);  
1
H NMR (500 MHz, 
CDCl3, ppm): δ = 7.45 - 7.29 (m, 10 H),  6.01 (m, 2H), 5.05 (m, 1H), 3.67 (q, 
J = 16.6 Hz, 2H), 1.82 (q, J = 7.7 Hz, 6H), 1.25 (t, J = 6.7 Hz, 6H),  0.87 (t, J 
= 7.7 Hz, 9H); 
13
C NMR (75.5 MHz, CDCl3, ppm): δ = 169.2, 167.8, 154.8, 
140.7, 138.0, 134.2, 131.3, 128.9, 128.1, 127.7, 126.5, 126.1, 125.6, 88.1, 69.6, 
50.4, 29.4, 27.0, 21.6, 7.7;  IR (film): 2974, 2939, 2881, 1716, 1701, 1622, 
1598, 1558 cm
-1
;  LRMS (ESI) m/z 543.1, 544.0 (M + Na
+
 ) HRMS (ESI) m/z 
543.2472, (M + Na
+
), calc. for C30H36N2O6
23
Na  543.2466.  The ee was 
determined by HPLC analysis. CHIRALCEL IA (4.6 mm i.d. x 250 mm); 
Hexane/2-propanol = 80/20; flow rate 1.0 ml/min; 25°C; 230 nm; retention 









yellow oil; 73% ee;  [α]29D  = -7.2 (c 0.26, CHCl3);  
1
H NMR (500 MHz, 
CDCl3, ppm): δ = 7.94 -7.29 (m, 7H),  7.24 (d, J = 8.6 Hz, 2H), 6.01 (m, 2H), 
5.05 (m, 1H), 3.67 (q, J = 16.6 Hz, 2H), 1.82 (q, J = 7.7 Hz, 6H), 1.25 (t, J = 
6.7 Hz, 6H),  0.87 (t, J = 7.7 Hz, 9H); 
13
C NMR (75.5 MHz, CDCl3, ppm): δ 
= 169.3, 169.2, 167.8, 164.1, 160.8, 154.7, 140.4, 134.2, 133.9, 131.1, 129.0, 
128.4, 128.3, 127.8, 125.9, 125.7, 116.0, 88.3, 69.7, 49.9, 29.4, 27.0, 21.6, 7.7;  
19
F NMR (282.4 MHz, CDCl3, ppm): - 37.9;  IR (film): 2974, 2941, 2881, 
1712, 1699, 1600, 1558  cm
-1
;  LRMS (ESI) m/z 561.0, 562.1 (M + Na
+
 ) 
HRMS (ESI) m/z 561.2387, (M + Na
+
), calc. for C30H35N2O6F1
23
Na  
561.2371.  The ee was determined by HPLC analysis. CHIRALCEL IA (4.6 
mm i.d. x 250 mm); Hexane/2-propanol = 90/10; flow rate 1.0 ml/min; 25°C; 
230 nm; retention time: 9.5 min, 13.8 min. 
  
yellow oil; 73% ee;  [α]29D  = -7.2 (c 0.26, CHCl3);  
1
H NMR (500 MHz, 
CDCl3, ppm): δ = 7.86 – 7.82 (m, 5H),  7.51 - 7.42 (m, 6H), 7.36 – 7.33 (d, J 






= 7.7 Hz, 6H), 1.25 (t, J = 6.7 Hz, 6H),  0.87 (t, J = 7.7 Hz, 9H); 
13
C NMR 
(75.5 MHz, CDCl3, ppm): δ = 169.3, 169.2, 167.8, 154.7, 140.6, 135.4, 134.3, 
133.3, 132.9, 131.2, 128.9, 128.0, 127.7, 126.4, 126.3, 126.1, 125.7, 125.5, 
124.3, 88.2, 69.7, 50.5, 29.5, 27.0, 21.6, 7.7;  IR (film): 2974, 2939, 2881, 
1712, 1697, 1598, 1558 cm
-1
;  LRMS (ESI) m/z 593.1, 594.1 (M + Na
+
 ) 
HRMS (ESI) m/z 593.2619, (M + Na
+
), calc. for C34H38N2O6
23
Na  593.2622.  
The ee was determined by HPLC analysis. CHIRALCEL IA (4.6 mm i.d. x 250 
mm); Hexane/2-propanol = 80/20; flow rate 1.0 ml/min; 25°C; 230 nm; 
retention time: 8.0 min, 10.7 min. 
 
4.2.7 Procedure for Enantioselective Deuteration Addition to 




    N-3-ethylpentan-3-yloxycarbonyl (Eoc) imine 83a (39.2 mg, 0.15 mmol, 
3.0 equiv.) and 65 (1.12 mg, 0.005 mmol, 0.1 equiv) were dissolved in 
Chloroform (0.3 ml) and D2O (0.1 ml) stirred at room temperature for 10 min, 
then 2-methylene-N-(3,5-diflurophenyl)succinimide 77 (11.2 mg, 0.05 mmol, 
1.0 equiv.) was added. The reaction mixture was stirred at room temperature 
and monitored by TLC. After 24 hours, upon complete consumption of 77, the 
reaction solvent was removed in vacuo and the crude product was directly 
loaded onto a short silica gel column, followed by gradient elution with 
hexane/EA mixtures (20/1 - 7/1 ratio). After removing the solvent, product 130 









yellow oil; 87% ee;  [α]29D  = -205.7  (c 0.7, CHCl3);  
1
H NMR (500 MHz, 
CDCl3, ppm): δ = 7.26 (d, J = 8.1 Hz, 2H), 7.18 (d, J = 8.1 Hz, 2H), 7.04 (m, 
2H), 6.81 (m, 1H), 5.90 (m, 2H), 2.33(S, 3H), 2.22 (s, 2.2H), 1.96 (q, J = 7.7 
Hz, 6H), 0.95 (t, J = 7.7 Hz, 9H); 
13
C NMR (75.5 MHz, CDCl3, ppm): δ = 
168.2, 163.4(d, J = 14.0 Hz), 160.0 (d, J = 14.0 Hz), 153.7, 137.7, 137.2, 136.9, 
134.2, 132.5, 128.8, 127.3, 125.4, 107.5 (q, J = 25.5 Hz), 102.3 (t, J = 25.5 Hz), 
87.2, 49.5, 26.0, 20.0, 8.1, 6.6;  
19
F NMR (282.4 MHz, CDCl3, ppm): 32.4 
(S);  IR (film): 2964, 2931, 2860, 1716, 1683, 1653, 1622, 1558 cm
-1
;  
LRMS (ESI) m/z 508.0, 509.0, (M + Na
+
 ), HRMS (ESI) m/z 508.2154 (M + 
Na
+
), calc. for C27H29D1F2N2O5
23
Na 508.2144.  The ee was determined by 
HPLC analysis. CHIRALCEL IA (4.6 mm i.d. x 250 mm); Hexane/2-propanol 
= 92/8; flow rate 0.8 ml/min; 25°C; 230 nm; retention time: 8.13 min, 8.8 min.  
  
yellow oil; 85% ee, dr: 99:1;  [α]29D  = +143.8 (c 0.83, CHCl3);  
1
H NMR 
(500 MHz, CDCl3, ppm): δ = 7.67 (d, J = 7.5 Hz, 2H), 7.57 (s, 1H), 7.55 - 7.32 






6.51 (d, J = 5.5 Hz, 2H), 6.16 (d, J = 9.0 Hz, 1H), 5.38 (dd, J = 9.0, 3.7 Hz, 
1H), 2.28 (s, 3H), 1.84 (q, J = 7.7 Hz, 6H), 0.88 (t, J = 7.8 Hz, 9H); 
13
C NMR 
(75.5 MHz, CDCl3, ppm): δ = 174.2, 168.5, 164.4, 161.1, 154.5, 138.4, 137.9, 
133.2, 132.8, 131.2, 130.9, 130.1, 129.8, 129.6, 129.2, 126.6, 123.9, 110.2, 
109.8, 104.3, 87.7, 52.8,  27.0, 20.9, 7.7;  
19
F NMR (282.4 MHz, CDCl3, 
ppm): 32.4;  IR (film): 2970, 2941, 2881, 1770, 1716, 1699, 1651, 1622, 
1558 cm
-1
;  LRMS (ESI) m/z 584.1, 585.1, (M + Na
+
 ), HRMS (ESI) m/z 
584.2434 (M + Na
+
), calc. for C33H33D1F2N2O4
23
Na 584.2457.  The ee was 
determined by HPLC analysis. CHIRALCEL IA (4.6 mm i.d. x 250 mm); 
Hexane/2-propanol = 80/20; flow rate 0.5 ml/min; 25°C; 230 nm; retention 
time: 7.3 min, 8.9 min. 
   
yellow oil; 77% ee;  [α]29D  = -26.1 (c 1.49, CHCl3);  
1
H NMR (500 MHz, 
CDCl3, ppm): δ = 7.45 (t, J = 7.8 Hz, 2H), 7.42 (d, J = 7.8 Hz, 3H), 7.28 (d, J = 
7.9 Hz, 2H), 7.17 (d, J = 7.9 Hz, 2H), 5.94 (s, 2H), 2.33 (s, 3H), 1.82 (q, J = 
7.7 Hz, 6H), 1.44 (s, 9H),  0.87 (t, J = 7.7 Hz, 9H); 
13
C NMR (75.5 MHz, 
CDCl3, ppm): δ = 169.5, 167.3, 154.8, 140.5, 137.9, 135.1, 134.3, 131.3, 129.6, 
129.2, 128.9, 127.7, 126.5, 125.7, 87.9, 82.5,  50.3, 27.8, 27.0, 21.0, 7.7;  IR 
(film): 2972, 2939, 2879, 1716, 1701, 1653, 1604, 1558 cm
-1
;  LRMS (ESI) 
m/z 573.1, 574.1 (M + Na
+
 ) HRMS (ESI) m/z 573.2927 (M + Na
+
), calc. for 
C32H36D2N2O6
23
Na  573.2924.  The ee was determined by HPLC analysis. 
CHIRALCEL IA (4.6 mm i.d. x 250 mm); Hexane/2-propanol = 80/20; flow 







4.2.8 Representative Procedure for the Synthesis of (E)-β,γ-Unsaturated 
Thioesters. 
 
    The carboxylic acid 3-hexenoic acid 134 (6 mmol) was dissolved in DCM 
(20 mL) under air and cooled to 0 °C. Aliphatic or aromatic thios 133 (6 mmol), 
DMAP (147 mg, 1.2 mmol) and DCC (1.48 g, 7.2 mmol) were then 
successively added. The reaction was then warmed to room temperature and 
stirred for 14 h. The precipitated DCU was filtered and the filterate was 
concentrated to an oil and then chromatographed over silica gel with ethyl 







H NMR (300 MHz, CDCl3, ppm): δ = 5.87-5.83 (m, 1H), 
5.67-5.62 (m, 1H), 3.42 (dd, J = 5.76, 0.99 Hz, 2H), 2.20 (qd, J = 7.41, 0.99 Hz, 






H NMR (300 MHz, CDCl3, ppm): δ = 5.86-5.82 (m, 1H), 
5.67-5.62 (m, 1H), 3.42 (dd, J = 5.76, 0.99 Hz, 2H), 2.20 (qd, J = 7.41, 0.99 Hz, 












H NMR (300 MHz, CDCl3, ppm): δ = 7.48 (d, J = 0.96 Hz, 
2H), 7.34 (q, J = 0.96 Hz, 1H), 5.86-5.80 (m, 1H), 5.66-5.62 (m, 1H), 3.42 (dd, 
J = 5.76, 0.99 Hz, 2H), 2.20 (qd, J = 7.41, 0.99 Hz, 2H), 1.09 (t, J = 7.41 Hz, 
3H). 
 
118d, 78% yield. 
1
H NMR (300 MHz, CDCl3, ppm): δ = 8.00 (d, J = 7.18 Hz, 
2H), 7.84 (d, J = 6.8 Hz, 1H), 7.59 (m, 3H), 7.24 (d, J = 6.8 Hz, 1H), 5.85-5.80 
(m, 1H), 5.66-5.62 (m, 1H), 3.43 (d, J = 6.78, 2H), 2.17 (q, J = 7.07 Hz, 2H), 
1.07 (t, J = 7.46 Hz, 3H).    
 
118e, 76% yield. 
1
H NMR (300 MHz, CDCl3, ppm): δ = 8.20 (d, J = 7.18 Hz, 
1H), 7.98 (d, J = 8.04, 1H), 7.92 (d, J = 6.84, 1H), 7.73 (d, J = 7.18 Hz, 1H), 
7.51-7.47 (m, 3H), 5.85-5.79 (m, 1H), 5.66-5.60 (m, 1H), 3.43 (d, J = 6.78 Hz, 
2H), 2.17 (q, J = 7.07 Hz, 2H), 1.07 (t, J = 7.46 Hz, 3H).  
13
C NMR (75 MHz, 
CDCl3, ppm): δ = 195.9, 138.4, 135.1, 134.4, 130.9, 128.7, 127.2, 126.4, 125.6, 
125.5, 125.3, 120.1, 47.4, 25.7, 13.5. 
 
    Na (460 mg, 10 equiv.) was washed with hexane and transferred into a 25 
mL flame dried two-necked round-bottom flask equipped with a magnetic bar 







using dry ice/acetone and NH3 gas was condensed into the reaction flask until a 
dark blue solution (around 10 ml) was formed. While stirring, a THF solution 
(1 ml) of the 3-en-1-ol 135 (250 μL, 2 mmol) was added dropwise into the dark 
blue solution at –78 °C. Stirring was continued at –78 °C for around 4 h, the 
reaction flask was opened to the air and brought to room temperature. Solid 
NH4Cl was added slowly with vigorous stirring until a white heterogeneous 
mixture was formed. After all NH3 was evaporated off, CH2Cl2 (5 mL) was 
added to the resulting white solid and was stirred for a half hour. The solid was 
then removed by suction filtration and was washed with CH2Cl2 (3×5 mL). The 
filtrate was combined and the solvent was removed under reduced pressure, 
giving alcohol 136. The crude product was used directly for the next reaction. 
 
136a, colorless oil, 80% yield. 
1
H NMR (300 MHz, CDCl3, ppm): δ = 
5.56-5.50 (m, 1H), 5.48-5.42 (m, 1H), 3.73 (t, J = 6.55 Hz, 2H), 1.83 (qt, J = 
6.55, 3.33 Hz, 2H), 1.67 (dd, J = 6.32, 1.11 Hz, 3H).   
 
136b, pale yellow oil, 80% yield. 
1
H NMR (500 MHz, CDCl3, ppm): δ = 
5.43-5.37 (m, 1H), 5.29-5.24 (m, 1H), 3.62 (t, J = 6.63 Hz, 2H), 2.96 (br, 1H), 
2.14-2.19 (m, 2H), 1.89-1.82 (m, 2H), 1.21-1.15 (m, 4H), 0.78 (t, J = 7.25 Hz, 
3H). 
13
C NMR (125 MHz, CDCl3, ppm): δ = 133.3, 125.9, 61.9, 35.9, 32.2, 
31.5, 22.1, 13.7. 
Compound 137 was prepared according to the general oxidation procedure.
[1]
 
To a solution of K2Cr2O7 (6 mg, 0.02 mmol, 1 mol%), 65% aq. HNO3 (39 
mg, 0.2 mmol, 10 mol%) and NaIO4 (941 mg, 4.4 mmol, 2.2 eq.) in H2O (2.15 
mL) were subsequently at 0°C added 4 mL of MeCN and 2.36 mL of 
(E)-3-en-1-ol 136 (2.0 g, 2 mmol, 1.0 eq.). The reaction mixture was stirred at 






filtrated off and washed with Et2O. The organic phase was separated and the 
aqueous phase was extracted with Et2O (3× 10 mL). The combined organic 
phases were dried (Na2SO4) and evaporated. The crude product was purified by 
flash chromatography which gave (70%) of the title compound 137 as a 
colorless liquid.  The compound 137 was further under coupling with thios to 
afford (E)-β,γ-unsaturated 1-naphthyl thioesters. 
 
118a, colorless oil, 65% yield. 
1
H NMR (500 MHz, CDCl3, ppm): δ = 
5.63-5.59 (m, 1H), 5.53-5.48 (m, 1H), 3.06 (d, J = 6.71 Hz, 2H), 1.67 (dd, J = 
6.32, 1.11 Hz, 3H).  
 
118b, pale yellow oil, 65% yield. 
1
H NMR (500 MHz, CDCl3, ppm): δ = 
5.62-5.58 (m, 1H), 5.52-5.47 (m, 1H), 3.06 (d, J = 6.9 Hz, 2H), 2.04 (q, J = 
6.60 Hz, 2H), 1.36-1.29 (m, 4H), 0.87 (t, J = 7.10 Hz, 3H). 
13
C NMR (125 
MHz, CDCl3, ppm): δ = 178.8, 135.5, 120.7, 37.8, 32.1, 31.2, 22.1, 13.8.  
 
118f, pale yellow oil, 75% yield.  
1
H NMR (500 MHz, CDCl3, ppm): δ = 8.20 
(d, J = 7.18 Hz, 1H), 7.98 (dd, J = 8.0, 6.8 Hz, 2H), 7.73 (d, J = 7.18 Hz, 1H), 
7.58-7.50 (m, 3H), 5.77-5.72 (m, 2H), 3.47-3.44 (m, 2H), 1.83-1.81 (m, 3H); 
13
C NMR (125 MHz, CDCl3, ppm): δ = 195.9, 135.1, 134.1, 133.5, 130.9, 








118j, pale yellow oil, 76% yield. 
1
H NMR (500 MHz, CDCl3, ppm): δ = 8.02 
(d, J = 7.89 Hz, 1H), 7.76 (d, J = 8.16 Hz, 1H), 7.71 (d, J = 7.02 Hz, 1H), 7.54 
(d, J = 7.02 Hz, 1H), 7.40-7.32 (m, 3H), 5.61-5.42 (m, 2H), 3.43 (d, J = 6.27 
Hz, 2H), 1.97-1.92 (m, 2H), 1.25-1.22 (m, 4H), 0.87 (t, J = 7.09 Hz, 3H). 
13
C 
NMR (125 MHz, CDCl3, ppm): δ = 195.9, 136.9, 135.0, 134.2, 130.8, 128.6, 
127.1, 126.4, 125.6, 125.3, 120.9, 47.3, 32.3, 31.2, 22.2, 13.9.  
General procedure for synthesis of 118g, 118h, 118i 
 
Piperidine 20 μL (0.20 mol, 0.01 eq.) and acetic acid 11.5 μL (0.20 mol, 
0.01 eq.) were stirred for 5 min in 0.5 mL DMSO at room temperature.  
Afterwards, malonic acid 138, aldehyde 139 in 10 mL DMSO were added and 
the reaction mixture was stirred under N2 atmosphere for 20 min.  The 
solution was stirred at 100 °C for 4-12 h.  The solution was cooled to room 
temperature and water 20 mL, Et2O 20 mL were added subsequentially.  The 
aqueous phase was extracted with Et2O, washed with water.  The combined 
organic phases were dried (Na2SO4) and evaporated. The crude product was 
purified by flash chromatography which gave quantitative 137 as a colorless 
liquid.  The compound 137 was further under coupling with thiols to afford 
(E)-β,γ-unsaturated 1-naphthyl thioesters. 
 
 
137a, colorless oil, 85% yield. 
1






1H), 5.59-5.46 (m, 2H), 3.04 (d, J = 6.27 Hz, 2H), 2.02-1.97 (m, 2H), 
1.41-1.34 (m, 2H), 0.87 (t, J = 7.09 Hz, 3H). 
13
C NMR (125 MHz, CDCl3, 
ppm): δ = 178.6, 135.1, 120.9, 37.7, 34.4, 22.1, 13.4.  
 
137b, colorless oil, 83% yield. 
1
H NMR (500 MHz, CDCl3, ppm): δ = 11.75 
(br, 1H), 5.56-5.42 (m, 2H), 3.04 (d, J = 6.30 Hz, 2H), 2.30-2.25 (m, 1H), 0.98 
(d, J = 6.3 Hz, 6H). 
13
C NMR (125 MHz, CDCl3, ppm): δ = 178.9, 142.1, 118.0, 
37.8, 30.9, 22.1.  
 
137c, colorless oil, 88% yield. 
1
H NMR (500 MHz, CDCl3, ppm): δ = 11.45 (br, 
1H), 7.41-7.38 (m, 2H), 7.32-7.28 (m, 3H), 5.88-5.82 (m, 1H), 5.76-5.70 (m, 
1H), 3.49 (d, J = 6.95 Hz, 2H), 3.21 (d, J = 6.30 Hz, 2H). 
13
C NMR (125 MHz, 
CDCl3, ppm): δ = 178.7, 140.0, 133.9, 128.6, 128.5, 126.2, 122.4, 38.9, 37.7.  
 
118g, colorless oil, 68% yield. 
1
H NMR (500 MHz, CDCl3, ppm): δ = 8.06 (d, 
J = 7.75 Hz, 1H), 7.97 (d, J = 7.78 Hz, 1H), 7.91 (d, J = 7.78 Hz, 1H), 7.75 (d,  
J = 7.65 Hz, 1H), 7.61-7.51 (m, 3H), 5.79-5.67 (m, 2H), 3.45 (d, J = 6.27 Hz, 
2H), 2.16-2.12 (m, 2H), 1.55-1.47 (m, 2H), 1.00 (t, J = 7.55 Hz, 3H).  
13
C 
NMR (75.5 MHz, CDCl3, ppm): δ = 195.7, 136.6, 134.9, 134.2, 134.1, 130.7, 
128.6, 127.0, 126.3, 125.5, 125.4, 125.2, 121.0, 47.3, 34.5, 22.1, 13.6. 
 
118h, colorless oil, 72% yield.  
1







J = 7.45 Hz, 1H), 7.98 (d, J = 7.58 Hz, 1H), 7.91 (d, J = 7.23 Hz, 1H), 7.77 (d,  
J = 6.90 Hz, 1H), 7.63-7.52 (m, 3H), 7.62 (d, J = 7.88 Hz, 1H), 5.79-5.64 (m, 
2H), 3.46 (d, J = 6.30 Hz, 2H), 2.46-2.41 (m, 1H), 1.13 (d, J = 6.95 Hz, 6H).  
13
C NMR (75.5 MHz, CDCl3, ppm): δ = 195.6, 143.5, 134.9, 134.2, 134.1, 
130.7, 128.5, 127.0, 126.2, 125.4, 125.2, 118.1, 47.1, 31.0, 22.1. 
 
118i, colorless oil, 71% yield. 
1
H NMR (500 MHz, CDCl3, ppm): δ = 8.10 (d, J 
= 7.88 Hz, 1H), 8.02-7.89 (m, 2H), 7.73-7.70 (m, 1H), 7.59-7.50 (m, 3H), 
7.37-7.31 (m, 2H), 7.27-7.24 (m, 3H), 5.93-5.87 (m, 1H), 5.78-5.72 (m, 1H), 
3.47-3.46 (m, 4H). 
13
C NMR (75 MHz, CDCl3, ppm): δ = 195.7, 139.8, 135.2, 
135.1, 134.2, 130.9, 128.6, 128.5, 127.2, 126.4, 126.2, 125.6, 126.2, 125.6, 
125.2, 122.5, 47.1, 39.0. 
General procedure for synthesis of 118k 
  
    1,3-Propanediol 7.2 mL (100 mmol, 1 eq.) was dissolved in 50 mL THF 
and cooled to 0 °C.  Sodium Hydride 8 g (200 mmol, 2 eq.) was slowly added 
and stirred for 5 min. TBDMSCl 18 g (120 mmol, 1.2 eq.) was dissolved in 30 
mL THF and added into the reaction mixture over 30 min. The reaction was 
stirred for overnight and quenched by saturated NH4Cl solution. The organic 
phase was separated and the aqueous phase was extracted with Et2O (3×20 mL). 
The combined organic phases were dried (Na2SO4) and evaporated. The crude 
product was purified by flash chromatography which gave (60%) of the 






    To a solution of oxalyl chloride (2.35 mL, 23 mmol) in DCM (60 mL) was 
added dropwise under nitrogen at –78 °C a solution of DMSO (4.3 mL, 60.5 
mmol) in DCM (13 mL) over 12 min.  During the addition the temperature 
was maintained at –78 °C.  The reaction mixture was stirred for 10 min, and a 
solution of 2-tert-butyldimethylsilyloxy-ethanol 141 (4.4 g, 25 mmol) and 
pyridine (4.4 mL, 50 mmol) in DCM (25 mL) was added over 12 min. The 
stirring was maintained for 15 min and triethylamine (17.5 mL, 125 mmol) was 
added over 8 min. After the addition, the mixture was warmed up to rt, and 
maintained at this temperature for an additional 20 min. 1N HCl was added to 
adjust the pH to 4, the phases were separated, the aqueous phase was extracted 
with DCM and the combined organic extracts were dried over MgSO4, filtered 
and evaporated. The residue was chromatographed on silica gel to give 67% 
yield of 142. 
1
H NMR (500 MHz, CDCl3, ppm): δ = 9.84 (s, 1H), 4.04 (t, J = 
10.1 Hz, 2H), 2.65 (t, J = 10.1 Hz, 2H), 0.91 (s, 9H), 0.10 (s, 6H). 
 
    2-tert-Butyldimethylsilyloxy-acetaldehyde 142 1.4 g (7.4 mmol, 1 eq.) 
and Methyl (Triphenylphosphoranylidene)acetate 2.5 g (7.4 mmol, 1 eq.) were 
dissolved in 30 mL THF and stirred for 4 h.  After reaction was completed, 
NH4Cl solution was added and the two layers were separated. Organic layer 
was dried over Na2SO4 and concentrated in vacuo.  Flash chromatograph on 
silica gel gave product in 80% yield. 
1
H NMR (500 MHz, CDCl3, ppm): δ = 
6.91 (m, 1H), 5.81 (d, J = 15.5 Hz, 1H), 3.66-3.62 (m, 5H), 2.35 (dt, J = 6.4, 
5.5 Hz, 2H), 0.80 (s, 9H), 0.01 (s, 6H); 
13
C NMR (125 MHz, CDCl3, ppm): δ = 
166.6, 145.9, 122.4, 61.3, 51.1, 35.6, 25.7, 18.1, -5.5.  







Diisobutylaluminium hydride 1.0 M solution (16 mL, 3 eq.) was added 
dropwise over 10 min. The reaction mixture was stirred at 0 °C for 2 h. 
Saturated sodium tartrate 10 min was added in one portion and further stirred 
for 1 h. The two layers were separated and organic layer was washed with Et2O 
(3×20 mL).  The combined organic layer was dried over Na2SO4 and 
concentrated in vacuo. Flash chromatograph on silica gel gave product in 85% 
yield. 
1
H NMR (500 MHz, CDCl3, ppm): δ = 5.65-5.73 (m, 2H), 4.13-4.05 (m, 
2H), 3.66 (t, J = 6.85 Hz, 2H), 2.29-2.25 (m, 2H), 0.90 (s, 9H), 0.05 (s, 6H). 
    The alcohol 250 mg (1.16 mmol, 1 eq.) was dissolved in THF 4 mL at 0 °C. 
60% Sodium hydride 56 mg (1.4 mmol, 1.2 eq.) was added at 0 °C and stirred 
for 10 min.  Benzyl bromide 119 μL (1.7 mmol, 1.5 eq.) was added dropwise 
over 10 min. The reaction was allowed to warm to room temperature and 
stirred overnight. Saturated NH4Cl solution was added and the two layers were 
separated. Organic layer was dried over Na2SO4 and concentrated in vacuo. 
Flash chromatograph on silica gel gave product in 70% yield. 
1
H NMR (500 
MHz, CDCl3, ppm): δ = 7.41-7.29 (m, 5H), 5.80-5.67 (m, 2H), 4.53 (s, 2H), 
4.02 (d, J = 5.95 Hz, 2H), 3.71 (t, J = 6.85 Hz, 2H), 2.34 (q, J = 6.85 Hz, 2H), 
0.94 (s, 9H), 0.09 (s, 6H); 
13
C NMR (125 MHz, CDCl3, ppm): δ = 138.4, 130.9, 
128.3, 128.2, 127.7, 127.4, 71.9, 70.8, 62.7, 35.9, 25.9, 18.3, -5.3.  
    The benzyl protected alcohol 146 mg (0.5 mmol, 1 eq.) was dissolved in 
THF 4 mL. Tetra-n-butylammonium fluoride 289 μL (1 mmol, 2 eq.) was 
added dropwise at 0 °C. The reaction was allowed to warm to room 
temperature and stirred for 1 h. Saturated NH4Cl solution was added and the 
two layers were separated. Organic layer was dried over Na2SO4 and 
concentrated in vacuo. Flash chromatograph on silica gel gave product 23 in 
70% yield. 
1
H NMR (500 MHz, CDCl3, ppm): δ = 7.35-7.26 (m, 5H), 






2H), 2.61 (br, 1H), 2.30-2.26 (m, 2H); 
13
C NMR (125 MHz, CDCl3, ppm): δ = 
138.2, 130.5, 129.0, 128.3, 127.8, 127.6, 72.2, 70.7, 61.7, 35.7. 




H NMR (500 MHz, CDCl3, ppm): δ = 8.12 (d, J = 7.88 Hz, 1H), 7.78 (d, 
J = 8.21 Hz, 1H), 7.89 (d, J = 6.65 Hz, 1H), 7.70 (d, J = 7.08 Hz, 1H), 7.58 (m, 
3H), 7.39-7.30 (m, 5H), 5.99-5.85 (m, 2H), 4.56 (s, 2H), 4.08 (dd, J = 5.45, 0.9 
Hz, 2H), 3.49 (dd, J = 6.85, 0.7 Hz, 2H). 
13
C NMR (125 MHz, CDCl3, ppm): δ 
= 195.1, 143.3, 138.1, 135.1, 135.0, 134.1, 132.2, 130.96, 130.88, 129.2, 128.6, 
127.7, 127.6, 125.6, 125.4, 125.1, 124.5, 72.1, 70.1, 46.8. 
General procedure for synthesis of 121a-g 
 
    490 mg of the alkyne 135 (5 mmol, 1 eq.) was dissolved in 10 mL of 
anhydrous ethyl acetate. In a separate flask, Pd/CaCO3/Pb (24 mg) was added 
to 6 ml of ethyl acetate. H2 was bubbled through the Pd/CaCO3/Pb solution for 
30 min after which the solution of alkyne was added and the reaction stirred for 
4 hrs under H2. The reaction was then filtered through a plug of Celite which 
was washed with CH2Cl2. Concentration in vacuo gave the crude alcohol as a 
colorless oil in 70% yield.  
    To a solution of K2Cr2O7 (6 mg, 0.02 mmol, 1 mol%), 65% aq. HNO3 (39 
mg, 0.2 mmol, 10 mol%) and NaIO4 (941 mg, 4.4 mmol, 2.2 eq.) in H2O (2.15 
mL) were subsequently at 0 °C added 4 mL of MeCN and 2.36 mL of the crude 







h and at 10 °C overnight (TLC conversion 98%). Inorganic salts were filtrated 
off and washed with Et2O. The organic phase was separated and the aqueous 
phase was extracted with Et2O (3×10 mL). The combined organic phases were 
dried (Na2SO4) and evaporated. The crude product was purified by flash 
chromatography which gave the title compound 144 as a yellowish liquid.  
 
Carboxylic acid 144 (1 mmol) was dissolved in DCM (20 mL) under air 
and cooled to 0 °C. Aliphatic thios or 4,4-dimethyloxazolidine-2-thione (1 
mmol), DMAP (14.7 mg, 0.12 mmol) and DCC (206 mg, 1.2 mmol) were then 
successively added. The reaction was then warmed to room temperature and 
stirred for 14 h. The precipitated DCU was filtered and the filterate was 
concentrated to an oil and then chromatographed over silica gel with ethyl 
acetate/hexanes (1/9) to afford the mixture of (Z)-β,γ-unsaturated thioesters 
121a-g. 
  
121a, colorless oil, 71% yield. 
1
H NMR (500 MHz, CDCl3, ppm): δ = 
5.61-5.66 (m, 1H), 5.48-5.43 (m, 1H), 3.21 (d, J = 7.36 Hz, 2H), 2.08-2.03 (m, 
2H), δ = 1.44 (s, 9H), 0.99 (t, J = 7.55 Hz, 3H).  
 
  
121b, colorless oil, 73% yield. 
1
H NMR (500 MHz, CDCl3, ppm): δ = 






2H), 1.82 (s, 2H), 1.54 (s, 6H), 1.01 (s, 9H), 0.99 (t, J = 7.55 Hz, 3H).   
 
121c, colorless oil, 77% yield.  
1
H NMR (500 MHz, CDCl3, ppm): δ = 
5.62-5.57 (m, 1H), 5.49-5.44 (m, 1H), 3.19 (d, J = 7.34 Hz, 2H), 2.15-2.10 (m, 
6H), 2.08-2.03 (m, 5H), 1.76-1.66 (m, 6H), 0.99 (t, J = 7.55 Hz, 3H).   
 
121d, colorless oil, 77% yield. 
1
H NMR (500 MHz, CDCl3, ppm): δ = 7.43 (d, 
J = 8.44 Hz, 2H), 7.33 (d, J = 8.52 Hz, 2H), 5.70-5.66 (m, 1H), 5.59-5.54 (m, 
1H), 3.20 (d, J = 7.34 Hz, 2H), 2.15-2.11 (m, 2H), 1.34 (s, 9H), 0.99 (t, J = 
7.55 Hz, 3H).   
 
121e, yellow oil, 71% yield. 
1
H NMR (500 MHz, CDCl3, ppm): δ = 7.96 (s, 
1H), 7.83-7.82 (m, 3H), 7.53-7.50 (m, 2H), 7.45 (dd, J = 8.45, 1.67 Hz, 1H), 
5.75-5.71 (m, 1H), 5.63-5.58 (m, 1H), 3.46 (d, J = 7.34 Hz, 2H), 2.19 (q, J = 








121f, yellow oil, 73% yield. 
1
H NMR (500 MHz, CDCl3, ppm): δ = 8.22 (d, J = 
8.22 Hz, 1H), 7.98 (d, J = 8.19 Hz, 1H), 7.92 (d, J = 7.99 Hz, 1H), 7.74 (d, J = 
7.73 Hz, 1H), 7.59-7.50 (m, 3H), 5.77-5.72 (m, 1H), 5.67-5.62 (m, 1H),  3.51 
(d, J = 6.95 Hz, 2H), 2.19 (q, J = 7.25 Hz, 2H), 1.07 (t, J = 7.58 Hz, 3H).  
13
C 
NMR (75.5 MHz, CDCl3, ppm): δ = 195.5, 136.9, 135.1, 134.2, 130.9, 128.7, 
127.1, 126.4, 125.6, 125.3, 119.6, 68.2, 42.3, 20.9, 13.9. 
 
121g, yellow oil, 82% yield. 
1
H NMR (500 MHz, CDCl3, ppm): δ = 5.72-5.68 
(m, 1H), 5.63-5.59 (m, 1H), 4.16 (s, 2H), 4.06 (d, J = 6.95 Hz, 2H), 1.65 (d, J = 
6.3 Hz, 3H), 1.56 (s, 6H). 
13
C NMR (125 MHz, CDCl3, ppm): δ = 186.6, 173.9, 
128.2, 121.5, 79.3, 65.9, 37.6, 24.1, 13.4. 
 
121h, yellow oil, 82% yield. 
1
H NMR (300 MHz, CDCl3, ppm): δ = 5.63-5.50 
(m, 2H), 4.15 (s, 2H), 4.05 (d, J = 6.72 Hz, 2H), 2.09 (q, J = 6.3 Hz, 2H), 1.55 
(s, 6H), 0.97 (t, J = 6.3 Hz, 3H). 
13
C NMR (75 MHz, CDCl3, ppm): δ = 186.5, 







121i, yellow oil, 83% yield. 
1
H NMR (500 MHz, CDCl3, ppm): δ = 5.63-5.51 
(m, 2H), 4.14 (s, 2H), 4.03 (d, J = 5.55 Hz, 2H), 2.05 (q, J = 6.3 Hz, 2H), 1.54 
(s, 6H), 1.32-1.30 (m, 4H), 0.87 (t, J = 6.3 Hz, 3H). 
13
C NMR (125 MHz, 
CDCl3, ppm): δ = 186.5, 173.9, 134.1, 120.3, 79.2, 65.8, 37.6, 31.4, 27.4, 24.0, 
22.2, 13.9. 
 
Representative Procedure for γ-Selective Direct allylic Amination of 



























    Dialkyl azodicarboxylate 119c (11.5 mg, 0.05 mmol, 2.0 equiv.) and 65 
(1.1 mg, 0.005 mmol, 0.1 equiv) were dissolved in methyl tert-butyl ether (0.5 
mL) and stirred at –50 °C for 20 min, then (E)-β,γ-unsaturated thioester 118 
(0.05 mmol, 1.0 equiv.) was added. The reaction mixture was stirred at –50 °C 
and monitored by TLC. After reaction was completed, upon complete 
consumption of 1, the reaction solvent was removed in vacuo and the crude 
product was directly loaded onto a short silica gel column, followed by 
gradient elution with hexane/EA (from 20/1 to 7/1). After removing the solvent, 













(Z)-β,γ-Unsaturated Thioesters with Di-tert-butyl Azodicarboxylate.  
 
    Dialkyl azodicarboxylate 119c (11.5 mg, 0.05 mmol, 2.0 equiv.) and 65 
(1.1 mg, 0.005 mmol, 0.1 equiv) were dissolved in organic solvent (0.5 mL) 
and stirred at certain temperature for 20 min, then (Z)-β,γ-unsaturated thioester 
121 (0.05 mmol, 1.0 equiv.) was added. The reaction mixture was stirred at 
certain temperature and monitored by TLC. After reaction was completed, 
upon complete consumption of 121, the reaction solvent was removed in vacuo 
and the crude product was directly loaded onto a short silica gel column, 
followed by gradient elution with hexane/EA (from 20/1 to 7/1). After 
removing the solvent, product 122 was obtained. 
 
120g, yellow oil; 92% ee; [α]29D  = –0.8 (c 1.0, CHCl3); 
1
H NMR (300 MHz, 
CDCl3, ppm): δ = 8.17 (d, J = 8.19 Hz, 1H), 7.95 (d, J = 8.16 Hz, 1H), 7.88 (d, 
J = 7.99 Hz, 1H), 7.71 (d, J = 7.02 Hz, 1H), 7.57-7.47 (m, 3H), 6.96-6.93 (m, 
1H), 6.36 (d, J = 15.48 Hz, 1H), 6.24 (br, 1H), 4.73 (br, 1H), 1.68-1.61 (m, 2H), 
1.49 (s, 18H), 0.96-0.89 (m, 3H). 
13
C NMR (75 MHz, CDCl3, ppm): δ = 187.8, 
155.7, 154.6, 143.0, 135.0, 134.3, 134.1, 130.9, 128.6, 127.1, 126.3, 125.5, 
125.3, 124.8, 81.69 (two peaks), 59.3 (broad peak), 28.14 (two peaks), 24.3 
(broad peak), 10.7. LRMS (ESI) m/z 508.9 (M + Na
+
), HRMS (ESI) m/z 
509.2100 (M + Na
+










The ee was determined by HPLC analysis. CHIRALCEL AD (4.6 mm i.d. x 
250 mm); Hexane/2-propanol = 80/20; flow rate 1.0 ml/min; 25°C; 230 nm; 
retention time: 14.4 min, 18.3 min. 
 
120h, yellow oil; 86% ee;  [α]29D  = –1.6 (c 1.0, CHCl3); 
1
H NMR (500 MHz, 
CDCl3, ppm): δ = 8.16 (d, J = 7.80 Hz, 1H), 7.96 (d, J = 8.25 Hz, 1H), 7.90 (d, 
J = 8.15 Hz, 1H), 7.71 (d, J = 7.10 Hz, 1H), 7.55-7.49 (m, 3H), 6.98 (br, 1H), 
6.29 (d, J = 14.45 Hz, 1H), 6.14 (br, 1H), 5.01 (br, 1H), 1.49 (s, 18H), 1.36 (d, 
J = 6.4 Hz, 3H). 
13
C NMR (125 MHz, CDCl3, ppm): δ = 187.8, 155.7, 154.4, 
144.7, 135.1, 134.3, 134.2, 131.0, 128.6, 127.6, 127.2, 126.4, 125.6, 125.4, 
124.8, 81.9 (two peaks), 52.9 (broad peak), 28.2 (two peaks), 16.5. LRMS (ESI) 
m/z 495.0 (M + Na
+
), HRMS (ESI) m/z 495.1937 (M + Na
+






The ee was determined by HPLC analysis. CHIRALCEL IA (4.6 mm i.d. x 250 
mm); Hexane/2-propanol = 85/15; flow rate 1.0 ml/min; 25°C; 230 nm; 
retention time: 14.8 min, 17.2 min. 
 
120i, yellow oil; 91% ee; [α]29D  = –0.6 (c 1.0, CHCl3); 
1
H NMR (500 MHz, 
CDCl3, ppm): δ = 8.17 (d, J = 7.10 Hz, 1H), 7.95 (d, J = 8.0 Hz, 1H), 7.89 (d, J 
= 7.30 Hz, 1H), 7.71 (d, J = 6.85 Hz, 1H), 7.53-7.49 (m, 3H), 6.95 (br, 1H), 
6.36-6.34 (m, 1H), 6.14 (br, 1H), 4.85 (br, 1H), 1.50-1.46 (m, 22H), 0.96 (t, J = 
6.4 Hz, 3H). 
13







135.1, 134.3, 134.1, 130.9, 128.6, 128.3, 127.1, 126.4, 125.6, 125.4, 81.8 (two 
peaks), 57.4 (broad peak), 33.2, 28.2, 19.2, 13.8. LRMS (ESI) m/z 522.9 (M + 
Na
+
), HRMS (ESI) m/z 523.2260 (M + Na
+






The ee was determined by HPLC analysis. CHIRALCEL IC (4.6 mm i.d. x 250 
mm); Hexane/2-propanol = 90/10; flow rate 1.0 ml/min; 25°C; 230 nm; 
retention time: 11.6 min, 14.8 min. 
 
120j, yellow oil; 96% ee; [α]29D  = –0.2 (c 1.0, CHCl3); 
1
H NMR (300 MHz, 
CDCl3, ppm): δ = 8.18 (d, J = 8.16 Hz, 1H), 7.95 (d, J = 8.16 Hz, 1H), 7.88 (d, 
J = 9.36 Hz, 1H), 7.72 (d, J = 6.72 Hz, 1H), 7.54-7.47 (m, 3H), 6.90 (br, 1H), 
6.39 (d, J = 15.48 Hz, 1H), 6.26 (br, 1H), 4.38 (br, 1H), 2.01 (br, 1H), 1.49 (s, 
9H), 1.48 (s, 9H), 1.02 (br, 2H), 0.91 (d, J = 6.72 Hz, 4H). 
13
C NMR (75 MHz, 
CDCl3, ppm): δ = 187.8, 156.0 (two peaks), 154.7, 141.6, 135.0, 134.3, 134.2, 
130.9, 129.6, 128.6, 127.1, 126.4, 125.6, 125.4, 124.9, 81.7 (broad peak), 64.1 
(broad peak), 29.7, 28.2 (two peaks), 19.6. LRMS (ESI) m/z 523.0 (M + Na
+
), 
HRMS (ESI) m/z 523.2252 (M + Na
+





The ee was determined by HPLC analysis. CHIRALCEL IC (4.6 mm i.d. x 250 
mm); Hexane/2-propanol = 90/10; flow rate 1.0 ml/min; 25°C; 230 nm; 








120k, yellow oil; 93% ee; [α]29D  = +0.6 (c 1.0, CHCl3); 
1
H NMR (300 MHz, 
CDCl3, ppm): δ = 8.22-8.09 (m, 1H), 7.95 (d, J = 7.89 Hz, 1H), 7.90-7.87 (m, 
1H), 7.70 (d, J = 6.00 Hz, 1H), 7.57-7.50 (m, 3H), 7.48-7.20 (m, 5H), 
7.07-6.98 (m, 1H), 6.46 (br, 1H), 5.73 (br, 1H), 5.33 and 4.82 (br, 1H), 3.50 
and 3.11 (m, 2H), 1.52-1.22 (m, 18H). 
13
C NMR (75 MHz, CDCl3, ppm): δ = 
187.8, 155.8, 154.3, 142.5, 138.3, 137.1, 135.1, 134.3, 134.1, 131.0, 129.1, 
128.7, 128.6, 128.5, 127.1, 126.8, 126.4, 125.6, 125.4, 124.8, 122.5, 82.3 (two 
peaks), 62.1 (broad peak), 39.0 (broad peak), 28.1. LRMS (ESI) m/z 571.0 (M 
+ Na
+
), HRMS (ESI) m/z 571.2251 (M + Na
+






The ee was determined by HPLC analysis. CHIRALCEL IA (4.6 mm i.d. x 250 
mm); Hexane/2-propanol = 80/20; flow rate 1.0 ml/min; 25°C; 230 nm; 
retention time: 14.3 min, 16.2 min. 
 
120l, yellow oil; 91% ee; [α]29D  = –0.3 (c 1.0, CHCl3); 
1
H NMR (300 MHz, 
CDCl3, ppm): δ = 8.17 (d, J = 8.19 Hz, 1H), 7.96 (d, J = 8.19 Hz, 1H), 
7.90-7.87 (m, 1H), 7.71 (d, J = 7.02 Hz, 1H), 7.54-7.48 (m, 3H), 7.06-6.87 (m, 
1H), 6.34 (d, J = 16.08 Hz, 1H), 6.10-5.92 (br, 1H), 4.82 (br, 1H), 1.57-1.35 (m, 
24H), 0.92 (br, 3H). 
13
C NMR (75 MHz, CDCl3, ppm): δ = 187.9, 155.7, 154.6 
(two peaks), 143.4, 135.1, 134.3, 134.1, 130.9, 128.6, 128.4, 127.1, 126.4, 







LRMS (ESI) m/z 537.0 (M + Na
+








The ee was determined by HPLC analysis. CHIRALCEL IC (4.6 mm i.d. x 250 
mm); Hexane/2-propanol = 90/10; flow rate 1.0 ml/min; 25°C; 230 nm; 
retention time: 11.6 min, 15.0 min. 
 
120m, yellow oil; 91% ee; [α]29D  = –0.7 (c 1.0, CHCl3); 
1
H NMR (500 MHz, CDCl3, ppm): 
δ = 8.11-8.03 (m, 1H), 7.95 (d, J = 8.20 Hz, 1H), 7.89 (d, J = 7.85 Hz, 1H), 7.71 (d, J = 
7.55 Hz, 1H), 7.55-7.47 (m, 3H), 7.38-7.33 (m, 5H), 6.92 (br, 1H), 6.49 (br, 1H), 6.14 (br, 
1H), 5.19 (b, 1H), 4.60-4.50 (m, 2H), 3.74-3.54 (m, 2H), 1.49(s, 9H), 1.48 (s, 9H). 
13
C 
NMR (75 MHz, CDCl3, ppm): δ = 187.6, 155.7, 154.8, 140.2, 137.6, 135.1, 134.1, 130.9, 
129.4, 128.5, 127.8, 127.1, 126.4, 125.5, 125.4, 81.9 (two peaks), 73.0, 68.7, 56.8 (broad 
peak), 28.2. LRMS (ESI) m/z 601.0 (M + Na
+







Na  601.2343. 
The ee was determined by HPLC analysis. CHIRALCEL IC (4.6 mm i.d. x 250 mm); 
Hexane/2-propanol = 80/20; flow rate 1.0 ml/min; 25°C; 230 nm; retention time: 12.1 min, 
19.6 min. 
 
122g, yellow oil; 85% ee; [α]29D  = +1.0 (c 1.0, CHCl3); 
1
H NMR (300 MHz, 
CDCl3, ppm): δ = 7.08 (d, J = 15.48 Hz, 1H), 6.91-6.70 (m, 1H), 6.39 (br, 1H), 
5.04 (br, 1H), 4.20 (s, 2H) 1.57 (s, 6H), 1.46 (s, 18H) 1.35 (d, J = 6.99 Hz, 3H). 
13






146.7, 124.2, 81.6 (two peaks), 79.8, 65.7, 52.4 (broad peak), 28.2, 23.9, 23.6, 
16.3. LRMS (ESI) m/z 465.9 (M + Na
+








The ee was determined by HPLC analysis. CHIRALCEL IC (4.6 mm i.d. x 250 
mm); Hexane/2-propanol = 80/20; flow rate 1.0 ml/min; 25°C; 230 nm; 
retention time: 8.6 min, 11.0 min. 
 
122h, yellow oil; 92% ee; [α]29D  = +1.3 (c 1.0, CHCl3); 
1
H NMR (300 MHz, 
CDCl3, ppm): δ = 7.08 (d, J = 15.45 Hz, 1H), 6.95-6.75 (m, 1H), 6.29 (br, 1H), 
4.76 (br, 1H), 4.20 (s, 2H) 1.80-1.69 (m, 2H), 1.58 (s, 6H), 1.46 (s, 18H) 1.01 
(br, 3H). 
13
C NMR (75  MHz, CDCl3, ppm): δ = 186.8, 166.9, 155.4 (two 
peaks), 154.9, 145.3, 125.1, 81.8 (two peaks), 79.8, 65.7, 58.9 (broad peak), 
28.2, 24.3, 23.8, 23.7, 10.9. LRMS (ESI) m/z 480.0 (M + Na
+
), HRMS (ESI) 
m/z 480.2153 (M + Na
+





The ee was determined by HPLC analysis. CHIRALCEL IC (4.6 mm i.d. x 250 
mm); Hexane/2-propanol = 80/20; flow rate 1.0 ml/min; 25°C; 230 nm; 
retention time: 10.4 min, 16.2 min. 
 
122i, yellow oil; 90% ee; [α]29D  = +0.8 (c 1.0, CHCl3); 
1
H NMR (500 MHz, 
CDCl3, ppm): δ = 7.07 (d, J = 15.1 Hz, 1H), 6.98-6.75 (m, 1H), 6.28 (br, 1H), 
4.83 (br, 1H), 4.19 (s, 2H) 1.84-1.67 (m, 2H), 1.57 (s, 6H), 1.46 (s, 18H) 
1.34-1.33 (m, 4H), 0.89 (t, J = 6.95 Hz, 3H). 
13
C NMR (75 MHz, CDCl3, ppm): 







79.8, 65.7, 57.2 (broad peak), 30.7, 28.2, 23.8, 23.7, 22.4, 13.9. LRMS (ESI) 
m/z 508.0 (M + Na
+
), HRMS (ESI) m/z 508.2463 (M + Na
+






The ee was determined by HPLC analysis. CHIRALCEL IA (4.6 mm i.d. x 250 
mm); Hexane/2-propanol = 80/20; flow rate 1.0 ml/min; 25°C; 230 nm; 
retention time: 8.3 min, 11.6 min. 
4.3 The Synthetic Application of Allylic Addition Products. 
  4.3.1 Experimental Procedure for the Esterification of 120g and 122b. 
 
    The amination product 120g 240 mg (0.5 mmol, 1 eq.) was dissolved in 
MeOH 5 mL. Potassium carbonate 138 mg (1 mmol, 2 eq.) was added and 
stirred at room temperature. The reaction mixture was monitored by TLC. After 
24 hours, upon complete consumption of 120g, the reaction was added by 5 mL 
brine and the two layers were separated. Organic layer was dried over Na2SO4 
and the solvent was removed in vacuo and the crude product was directly 
loaded onto silica gel column, followed by elution with hexane/EA (10/1). 
After removing the solvent, product E-(S)-123 was obtained as colorless oil in 
80% yield. 
1
H NMR (300 MHz, CDCl3, ppm): δ = 6.95-6.78 (m, 1H), 6.16 (br, 






0.92 (br, 3H). 
13
C NMR (75 MHz, CDCl3, ppm): δ = 166.7, 155.8, 154.6, 145.8, 
122.0, 81.6, 59.5, 51.5, 28.1, 24.3, 10.7.   
The ee was determined by HPLC analysis. CHIRALCEL IC (4.6 mm i.d. x 250 
mm); Hexane/2-propanol = 90/10; flow rate 1.0 ml/min; 25°C; 230 nm; 
retention time: 7.1 min, 8.8 min. 
  
4.3.2 Determination of the Absolute Configurations of Adducts. 
 
1. Absolute configurations of 120 was determined by 120 derivative X-ray 
structure analysis. 
2. 120 Derivative was synthesized by two step pathway. 
 
 
4.3.3 Synthesis of γ-Amino Acid Derivative 146. 
 
    The methyl ester E-(S)-123 72 mg (0.2 mmol, 1 eq.) was dissolved in 
DCM 3 mL. TFA 2 mL was added and stirred at 0 °C. After 3 hours, the solvent 
was removed in vacuo and the crude product was dissolved in MeOH 4 mL. 
The reaction solution was treat with Raney-Ni (30 eq.) and stirred under H2 (3 
atm) atmosphere for 24 h. The reaction mixture was filtered over celite and 
concentrated to give crude amino. The crude amino was dissolved in DCM 2 
mL. iPr2Net 76 mg (0.6 mmol, 3 eq.) and Boc2O 48 mg (0.22 mmol, 1.1 eq.) 
were added. After the reaction mixture was stirred overnight. The solvent was 







column, followed by gradient elution with hexane/EA (15/1 to 7/1). After 
removing the solvent, product (S)-146 was obtained as colorless oil in 60% 
yield. 
1
H NMR (300 MHz, CDCl3, ppm): δ = 4.28 (d, J = 8.04 Hz, 1H), 3.66 (s, 
3H), 3.49 (br, 1H), 2.37 (t, J = 7.56 Hz, 2H), 1.87-1.80 (m, 2H), 1.63-1.44 (m, 
2H), 1.42 (s, 9H), 0.86 (t, J = 6.1 Hz, 3H). 
13
C NMR (75 MHz, CDCl3, ppm): δ 
= 174.1, 155.8, 79.0, 51.7, 51.6, 30.9, 30.1, 28.5, 28.4, 10.2.  LRMS (ESI) 
m/z 268.0 (M + Na
+
). 
4.3.4 Dihydroxylation of E-(S)-120j. 
    The amination product (E)-S-120j 150 mg (0.3 mmol, 1 eq.) was 
dissolved in MeOH 4 mL. Potassium carbonate 83 mg (0.4 mmol, 2 eq.) was 
added and stirred at room temperature. The reaction mixture was monitored by 
TLC. After 24 hours, upon complete consumption of (E)-S-120j, the reaction 
was added by 10 mL brine and the two layers were separated. Organic layer 
was dried over Na2SO4 and the solvent was removed in vacuo and the crude 
product was directly loaded onto silica gel column, followed by elution with 
hexane/EA (10/1) gave the methyl ester.  
    To a solution of methyl ester 74 mg (0.2 mmol, 1 eq.) and NMO 70.3 mg 
(0.6 mmol, 3 eq.) in 4 mL THF-H2O (1:1), was added OsO4 (5.1 mg, 0.1 eq.) 
and the reaction mixture was stirred at room temperature for 40 h. The reaction 
was quenched with saturated sodium bisulfate solution (10 mL), extracted with 
ethyl acetate (3×10 mL). The combined organic layers were washed with brine, 
dried over anhydrous Na2SO4 and concentrated under reduced pressure to give 






using hexane/EA (2/1 to 1/1) to afford pure diol 148 (148a/148b = 9/1) in 68% 
yield over two steps.  
148a: 
1
H NMR (300 MHz, CDCl3, ppm): δ = 6.25 (br, 1H), 5.23 (br, 1H), 
4.26-4.03 (m, 3H), 3.79 (s, 3H), 3.27 (br, 1H), 2.12-1.95 (m, 1H), 1.45-1.42 (m, 
18H), 0.97 (brs, 6H). 
13
C NMR (75 MHz, CDCl3, ppm): δ = 173.4, 156.1, 82.2, 
81.6, 71.8, 71.3, 70.0, 63.6, 52.6, 28.6, 28.0, 20.3, 20.1.  LRMS (ESI) m/z 
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X-ray Structure Analysis. 
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